{"content":"<li class=\"n-box-item date-title\" data-end=\"1526961599\" data-start=\"1526875200\" data-txt=\"Monday, December 23, 2019\">Monday, May 21, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3358418\" data-ts=\"1526942448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358418-shopifyminus-2_4-after-adobe-announces-deal-for-rival-magento\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify -2.4% after Adobe announces deal for rival Magento</a></h4><ul>     <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) falls by as much as 5.5% following Adobe Systems&rsquo; (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) <a href=\"https://seekingalpha.com/news/3358356-adobe-acquires-commerce-platform-company-1_6b\" target=\"_blank\">agreement to buy</a> commerce platform company Magento for $1.68B; SHOP now <font color='red'>-2.4%</font> after-hours.</li>     <li>SHOP competes against Magento in providing software to build and run web stores and process online orders.</li>     <li>Through today&rsquo;s close, SHOP shares were up 43% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358418\" data-linked=\"Shopify -2.4% after Adobe announces deal for rival Magento\" data-tweet=\"$SHOP $SHOP $ADBE - Shopify -2.4% after Adobe announces deal for rival Magento https://seekingalpha.com/news/3358418-shopifyminus-2_4-after-adobe-announces-deal-for-rival-magento?source=tweet\" data-url=\"https://seekingalpha.com/news/3358418-shopifyminus-2_4-after-adobe-announces-deal-for-rival-magento\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358417\" data-ts=\"1526940887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDSN\" target=\"_blank\">NDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358417-nordsonminus-5-despite-strong-q2-after-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordson -5% despite strong Q2 after weak guidance</a></h4><ul>     <li>Nordson (NASDAQ:<a href='https://seekingalpha.com/symbol/NDSN' title='Nordson Corporation'>NDSN</a>) <font color='red'>-5.4%</font> after-hours as it reports better than expected <a href=\"https://seekingalpha.com/news/3358370-nordson-beats-0_13-beats-revenue\" target=\"_blank\">FQ2 earnings</a> and in-line revenues but guides Q3 revenues below consensus.</li>     <li>NDSN sees Q3 GAAP EPS of $1.47-$1.63, which may not be comparable to $1.91 analyst consensus estimate, with sales forecast in the range of +1% to -3%  compared to the year-ago quarter, which would equate to $571M-$595M vs. $620M consensus.</li>     <li>Backlog for the quarter ended April 30 was ~$460M, up 11% Y/Y, including 10% organic growth  and 1% growth due to acquisitions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358417\" data-linked=\"Nordson -5% despite strong Q2 after weak guidance\" data-tweet=\"$NDSN - Nordson -5% despite strong Q2 after weak guidance https://seekingalpha.com/news/3358417-nordsonminus-5-despite-strong-q2-after-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3358417-nordsonminus-5-despite-strong-q2-after-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358408\" data-ts=\"1526938553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358408-after-hours-gainers-losers-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (05/21/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>&nbsp;<font color='green'>+7.8%</font>. <a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics'>NBRV</a>&nbsp;<font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>&nbsp;<font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+1.8%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='red'>-7.3%</font>. <a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics'>MLNT</a>&nbsp;<font color='red'>-6.9%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/SAIL' title='SailPoint Technologies'>SAIL</a>&nbsp;<font color='red'>-6.4%.&nbsp;</font><a href='https://seekingalpha.com/symbol/NDSN' title='Nordson Corporation'>NDSN</a>&nbsp;<font color='red'>-4.8%</font>. <a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;CAYMAN&#41; Ltd.'>NETS</a>&nbsp;<font color='red'>-4.00%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358408\" data-linked=\"After Hours Gainers / Losers (05/21/2018)\" data-tweet=\"$SESN $SESN $NBRV - After Hours Gainers / Losers (05/21/2018) https://seekingalpha.com/news/3358408-after-hours-gainers-losers-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358408-after-hours-gainers-losers-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358401\" data-ts=\"1526936839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358401-micronplus-2_9-on-10b-share-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron +2.9% on $10B share repurchase program</a></h4><ul><li>        Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) <a href=\"https://seekingalpha.com/pr/17169745-micron-announces-10-billion-share-repurchase-authorization\" target=\"_blank\">announces</a> a $10B share repurchase program.</li><li>               The program was announced in conjunction with plans to return at least 50% of FCF to investors beginning in FY19.&nbsp;</li><li>               Micron shares are&nbsp;<font color='green'>up 2.9%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-analyst-day-shares-plus-4_1-percent\" target=\"_blank\">Micron raises Q3 guidance ahead of analyst day; shares +4.1%</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358401\" data-linked=\"Micron +2.9% on $10B share repurchase program\" data-tweet=\"$MU - Micron +2.9% on $10B share repurchase program https://seekingalpha.com/news/3358401-micronplus-2_9-on-10b-share-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3358401-micronplus-2_9-on-10b-share-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>172&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358391\" data-ts=\"1526935965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358391-ardelyx-readies-stock-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx readies stock offering; shares down 8% after hours</a></h4><ul><li>Thinly traded micro cap Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx'>ARDX</a>) slips&nbsp;<font color='red'>8%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/17169612-ardelyx-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned $50M public offering </a>of common stock. Price, volume and terms have yet to be announced.</li><li>Separately, it inked a <a href=\"https://seekingalpha.com/pr/17169619-ardelyx-raises-50-million-loan-agreement-solar-capital-bridge-bank\" target=\"_blank\">$50M senior secured bridge loan</a> facility with Solar Capital Alliance Bank that was fully funded on May 16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358391\" data-linked=\"Ardelyx readies stock offering; shares down 8% after hours\" data-tweet=\"$ARDX - Ardelyx readies stock offering; shares down 8% after hours https://seekingalpha.com/news/3358391-ardelyx-readies-stock-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3358391-ardelyx-readies-stock-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358371\" data-ts=\"1526934854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGEN\" target=\"_blank\">FGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358371-fibrogens-pamrevlumab-shows-treatment-effect-in-mid-stage-ipf-study-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FibroGen&#39;s pamrevlumab shows treatment effect in mid-stage IPF study; shares up 2% after hours</a></h4><ul><li>FibroGen (NASDAQ:<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a>) is up&nbsp;<font color='green'>2%&nbsp;</font>after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17169605-fibrogen-presents-latest-data-praise-phase-2b-study-pamrevlumab-idiopathic-pulmonary-fibrosis\" target=\"_blank\">announcement </a>of positive results from a Phase 2b clinical trial, PRAISE, evaluating pamrevlumab in patients with idiopathic pulmonary fibrosis &#40;IPF&#41;. The data were presented at the American Thoracic Society Conference in San Diego.</li><li>At week 24, the change from baseline in quantitative lung fibrosis &#40;QLF&#41; volume in the treatment group was 24.8 mL compared to 86.4 mL for placebo (p=0.0090) (the lower number indicates less fibrosis). At week 48, the QLF change from baseline was 75.4 mL in the pamrevlumab group versus 151.5 mL for placebo (p=0.038).</li><li>Phase 3-stage&nbsp;<a href=\"http://www.fibrogen.com/pamrevlumab/\" target=\"_blank\">pamrevlumab&nbsp;</a>is a fully human monoclonal antibody that binds to (inhibits) the activity of connective tissue growth factor &#40;CTGF&#41;, a protein that plays a key role in the progression of fibrosis (scarring) and related diseases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358371\" data-linked=\"FibroGen&#39;s pamrevlumab shows treatment effect in mid-stage IPF study; shares up 2% after hours\" data-tweet=\"$FGEN - FibroGen&#39;s pamrevlumab shows treatment effect in mid-stage IPF study; shares up 2% after hours https://seekingalpha.com/news/3358371-fibrogens-pamrevlumab-shows-treatment-effect-in-mid-stage-ipf-study-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3358371-fibrogens-pamrevlumab-shows-treatment-effect-in-mid-stage-ipf-study-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358365\" data-ts=\"1526934579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358365-pure-storageminus-6_6-on-q1-beats-product-margin-drop-in-line-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Storage -6.6% on Q1 beats with product margin drop, in-line guide</a></h4><ul><li>        Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>)&nbsp;<font color='red'>drops 6.6%</font>&nbsp;aftermarket on Q1 results that beat EPS and revenue estimates with a 40% Y/Y revenue growth. In-line Q2 guidance has revenue of $296M to $304M (consensus: $299.43M). Non-GAAP gross margin expected from 63.5% to 66.5% and operating margin from -7% to -3%.</li><li>               In-line FY19 guidance has revenue from $1.32B to $1.37B (consensus: $1.34B). Non-GAAP gross margin expected from 63.5% to 66.5% and operating margin from 0% to 4%.&nbsp;</li><li>               Key metrics: Non-GAAP gross margin, 66.3% (-0.1 pts Y/Y); product gross margin, 66.3% (-1.3 pts); support subscription gross margin, 66.3% (+4.2 pts); operating margin, -6% (+7.9 pts); operating cash flow, $18.6M; FCF (ex-ESPP impact), $8.6M; customer add, 300 (total: 4.8K).&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://investor.purestorage.com/investor-home/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17169633-pure-storage-announces-first-quarter-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358349-pure-storage-beats-0_05-beats-revenue\" target=\"_blank\">Pure Storage beats by $0.05, beats on revenue</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358365\" data-linked=\"Pure Storage -6.6% on Q1 beats with product margin drop, in-line guide\" data-tweet=\"$PSTG - Pure Storage -6.6% on Q1 beats with product margin drop, in-line guide https://seekingalpha.com/news/3358365-pure-storageminus-6_6-on-q1-beats-product-margin-drop-in-line-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3358365-pure-storageminus-6_6-on-q1-beats-product-margin-drop-in-line-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358357\" data-ts=\"1526933858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOK\" target=\"_blank\">MYOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358357-myokardia-launches-stock-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MyoKardia launches stock offering; shares down 3% after hours</a></h4><ul><li>MyoKardia (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a>) <a href=\"https://seekingalpha.com/pr/17169615-myokardia-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of 3.75M shares of common stock. Underwriters over-allotment is an additional 562.5K shares. Price and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>3%&nbsp;</font>after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358357\" data-linked=\"MyoKardia launches stock offering; shares down 3% after hours\" data-tweet=\"$MYOK - MyoKardia launches stock offering; shares down 3% after hours https://seekingalpha.com/news/3358357-myokardia-launches-stock-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3358357-myokardia-launches-stock-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358356\" data-ts=\"1526933838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358356-adobe-acquires-commerce-platform-company-for-1_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe acquires commerce platform company for $1.6B</a></h4><ul><li>Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) <a href=\"http://news.adobe.com/press-release/corporate/adobe-acquire-magento-commerce\" target=\"_blank\">will acquire</a> commerce platform company Magento Commerce for $1.68B.</li><li>Magento&rsquo;s platform combines digital commerce, order management, and predictive intelligence across shopping experiences. Current Magento clients include Canon, Paul Smith, and Rosetta Stone.</li><li>The Magento Commerce Cloud product will join the Adobe Experience Cloud.</li><li>The deal is expected to close in Adobe&rsquo;s Q3 and each company will continue to operate independently after the close.</li><li>Adobe shares are&nbsp;<font color='green'>up 1.2%</font>&nbsp;aftermarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358356\" data-linked=\"Adobe acquires commerce platform company for $1.6B\" data-tweet=\"$ADBE - Adobe acquires commerce platform company for $1.6B https://seekingalpha.com/news/3358356-adobe-acquires-commerce-platform-company-for-1_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3358356-adobe-acquires-commerce-platform-company-for-1_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358346\" data-ts=\"1526932713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358346-ge-sheds-part-of-days-gain-after-gasparino-tweets-dividend-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE sheds part of day&#39;s gain after Gasparino tweets about further dividend cut</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+1.8%</font>) slips to its lowest levels of the day - although shares are still in the green - after Fox Business's Charles Gasparino <a href=\"https://twitter.com/CGasparino/status/998648772581363714\" target=\"_blank\">tweets about a potential dividend cut</a> at the company.</li>     <li>\"GE insiders say further dividend cut or elimination possible as CEO Flannery scrambles to reduce costs,\"&nbsp;Gasparino tweets, adding that Flannery is coming up  on his one-year anniversary as CEO still short of his goal of cutting $20B in costs despite today's <a href=\"https://seekingalpha.com/news/3358144-wabtec-ge-transportation-merge\" target=\"_blank\">Wabtec transportation deal</a>.</li><li><a href=\"https://seekingalpha.com/news/3358335-ge-jumps-three-month-highs-analysts-praise-wabtec-deal\" target=\"_blank\">Earlier</a>: GE jumps to three-month highs as analysts praise Wabtec deal (May 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358346\" data-linked=\"GE sheds part of day&#39;s gain after Gasparino tweets about further dividend cut\" data-tweet=\"$GE - GE sheds part of day&#39;s gain after Gasparino tweets about further dividend cut https://seekingalpha.com/news/3358346-ge-sheds-part-of-days-gain-after-gasparino-tweets-dividend-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3358346-ge-sheds-part-of-days-gain-after-gasparino-tweets-dividend-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358344\" data-ts=\"1526931981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TM\" target=\"_blank\">TM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358344-toyota-preps-for-ix4-roll-out-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toyota preps for ix4 roll-out in China</a></h4><ul><li>Toyota (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color='green'>+0.2%</font>) plans to start selling the <a href=\"https://www.reuters.com/article/us-toyota-china-gac-exclusive/exclusive-toyota-plans-to-roll-into-chinas-ev-market-in-gac-motor-vehicle-idUSKCN1IJ07K\" target=\"_blank\">ix4</a> compact crossover in China by the end of the year.</li><li>The company is using the nameplate of Chinese partner GAC Motors on the model to help it meet EV selling requirements in China.</li><li>Other GAC models are starting to stack up well in global markets, according to automobile industry experts.</li><li>GAC Motors is a 50-50 joint venture between Guangzhou Automobile Group's (<a href='https://seekingalpha.com/symbol/GNZUF' title='Guangzhou Automobile Group Co., Ltd.'>OTCPK:GNZUF</a>) GAC Group and Toyota.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358344\" data-linked=\"Toyota preps for ix4 roll-out in China\" data-tweet=\"$TM $TM $GNZUF - Toyota preps for ix4 roll-out in China https://seekingalpha.com/news/3358344-toyota-preps-for-ix4-roll-out-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3358344-toyota-preps-for-ix4-roll-out-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358343\" data-ts=\"1526931727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LHO\" target=\"_blank\">LHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358343-reits-trade-up-lasalle-hotel-takeover-battle-highlights-category\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REITs trade up as LaSalle Hotel takeover battle highlights category</a></h4><ul><li>Hotel REIT stocks took center stage today as a battle for LaSalle Hotel Properties (<a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='green'>+5.6%</font>) began, with Blackstone agreeing to buy LHO for $33.50 a share, and Pebblebrook Hotel Trust (<a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color='green'>+1.8%</font>) rallying with a sweetened stock swap offer valued at about $35.89.</li><li>REITs, overall, traded up in afternoon trading. Here's a sampling from each subcategory:</li><li>Mortgage: CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='green'>+2.2%</font>)</li><li>Triple-net: Spirit Realty Capital (<a href='https://seekingalpha.com/symbol/SRC' title='Spirit Realty Capital'>SRC</a> <font color='green'>+2.2%</font>)</li><li>Healthcare: Sabra Healthcare (<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a> <font color='green'>+2.4%</font>)</li><li>Senior: Senior Housing Properties (<a href='https://seekingalpha.com/symbol/SNH' title='Senior Housing Properties Trust'>SNH</a> <font color='green'>+2.3%</font>)</li><li>Mall: Tanger Factory Outlet Centers (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='green'>+2.6%</font>)</li><li>Shopping center: Kimco Realty (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='green'>+4.3%</font>)</li><li>Industrial: Lexington Realty Trust (<a href='https://seekingalpha.com/symbol/LXP' title='Lexington Realty Trust'>LXP</a> <font color='green'>+1.8%</font>)</li><li>Office: Government Properties Income (<a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a> <font color='green'>+1.9%</font>)</li><li>Sale/leaseback: Global Net Lease (<a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a> <font color='green'>+1.5%</font>)</li><li>Commercial mortgage: Colony Northstar (CLNS <font color='green'>+2.5%</font>)</li><li>Apartment: Preferred Apartment Communities (<a href='https://seekingalpha.com/symbol/APTS' title='Preferred Apartment Communities'>APTS</a> <font color='green'>+1.9%</font>)</li><li>Prison: Corecivic (<a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a> <font color='green'>+1.7%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a>, <a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a>, <a href='https://seekingalpha.com/symbol/RQI' title='Cohen&Steers Quality Income Realty Fund'>RQI</a>, <a href='https://seekingalpha.com/symbol/SCHH' title='Schwab U.S. REIT ETF'>SCHH</a>, <a href='https://seekingalpha.com/symbol/RNP' title='Cohen&Steers REIT&Preferred Income Fund'>RNP</a>, <a href='https://seekingalpha.com/symbol/RFI' title='Cohen&Steers Total Return Realty Fund'>RFI</a>, <a href='https://seekingalpha.com/symbol/KBWY' title='Invesco KBW Premium Yield Equity REIT Portfolio ETF'>KBWY</a>, <a href='https://seekingalpha.com/symbol/DRN' title='Direxion Daily Real Estate Bull 3x Shares ETF'>DRN</a>, <a href='https://seekingalpha.com/symbol/NRO' title='Neuberger Berman Real Estate Securities Income Fund'>NRO</a>, <a href='https://seekingalpha.com/symbol/URE' title='ProShares Ultra Real Estate ETF'>URE</a>, <a href='https://seekingalpha.com/symbol/ICF' title='iShares Cohen & Steers REIT ETF'>ICF</a>, <a href='https://seekingalpha.com/symbol/XLRE' title='Real Estate Select Sector SPDR ETF'>XLRE</a>, <a href='https://seekingalpha.com/symbol/JRS' title='Nuveen Real Estate Income Fund'>JRS</a>, <a href='https://seekingalpha.com/symbol/RWR' title='SPDR Dow Jones REIT ETF'>RWR</a>, <a href='https://seekingalpha.com/symbol/SRS' title='ProShares UltraShort Real Estate ETF'>SRS</a>, <a href='https://seekingalpha.com/symbol/FREL' title='Fidelity MSCI Real Estate Index ETF'>FREL</a>, <a href='https://seekingalpha.com/symbol/DRA' title='Diversified Real Asset Income Fund'>DRA</a>, <a href='https://seekingalpha.com/symbol/DRV' title='Direxion Daily Real Estate Bear 3x Shares ETF'>DRV</a>, <a href='https://seekingalpha.com/symbol/RIF' title='RMR Real Estate Income Fund'>RIF</a>, <a href='https://seekingalpha.com/symbol/LRET' title='ETRACS Monthly Pay 2xLeveraged MSCI US REIT Index ETN'>LRET</a>, <a href='https://seekingalpha.com/symbol/REK' title='ProShares Short Real Estate ETF'>REK</a>, <a href='https://seekingalpha.com/symbol/RIT' title='LMP Real Estate Income Fund'>RIT</a>, <a href='https://seekingalpha.com/symbol/FRI' title='First Trust S&P REIT Index ETF'>FRI</a>, <a href='https://seekingalpha.com/symbol/FTY' title='iShares Real Estate 50 ETF'>FTY</a>, <a href='https://seekingalpha.com/symbol/PSR' title='Inv Act Man Exg Shs'>PSR</a>, <a href='https://seekingalpha.com/symbol/USRT' title='iShares Core U.S. REIT ETF'>USRT</a>, <a href='https://seekingalpha.com/symbol/WREI' title='Invesco Wilshire U.S. Real Estate Investment Trust ETF'>WREI</a>, <a href='https://seekingalpha.com/symbol/IARAX' title='Invesco Real Estate Fund A'>IARAX</a>, <a href='https://seekingalpha.com/symbol/RORE' title='Hartford Multifactor REIT ETF'>RORE</a>, <a href='https://seekingalpha.com/symbol/PPTY' title='U.S. Diversified Real Estate ETF'>PPTY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3358343\" data-linked=\"REITs trade up as LaSalle Hotel takeover battle highlights category\" data-tweet=\"$LHO $LHO $PEB - REITs trade up as LaSalle Hotel takeover battle highlights category https://seekingalpha.com/news/3358343-reits-trade-up-lasalle-hotel-takeover-battle-highlights-category?source=tweet\" data-url=\"https://seekingalpha.com/news/3358343-reits-trade-up-lasalle-hotel-takeover-battle-highlights-category\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358339\" data-ts=\"1526931141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358339-sesen-bios-lead-adc-shows-treatment-effect-in-late-stage-bladder-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sesen Bio&#39;s lead ADC shows treatment effect in late-stage bladder cancer study</a></h4><ul><li>In what appears to be \"selling on the news,\" Sesen Bio (<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a> <font color='red'>-21.3%</font>) is down on almost a 20% bump in volume despite its <a href=\"https://seekingalpha.com/pr/17169552-phase-3-registration-trial-non-muscle-invasive-bladder-cancer-achieves-42-percent-complete\" target=\"_blank\">announcement </a>positive results from the Phase 3 VISTA study assessing lead antibody-drug conjugate &#40;ADC&#41; Vicinium in patients with high-grade non-muscle invasive bladder cancer &#40;NMIBC&#41;. Shares had more than tripled since March.</li><li>At month 3, evaluable patients with carcinoma in situ &#40;CIS&#41; (cancer is confined to the inner lining of the bladder) experienced a complete response rate of 39% (n=28/72). In patients with CIS with or without papillary disease (cancer has spread into the bladder but not to other tissues), the response rate was 80% (n=4/5).</li><li>The response rate was 42% (n=32/77) in a pooled group from the above patients based on FDA guidance on BCG-resistant CIS NMIBC patients (recurrent CIS within 12 months of BCG (bacillus Calmette-Gu&eacute;rin) therapy, the current standard of care).</li><li>In patients with papillary disease without CIS, treatment with Vicinium produced a 68% recurrence-free rate at month 3 (these patients underwent mandatory surgery before treatment).</li><li>On the safety front, 72% of adverse events (AEs) were mild or moderate. 4% were serious or life-threatening. These included acute kidney injury or renal failure and cholestatic hepatitis.</li><li><a href=\"http://www.elevenbio.com/pipeline/vicinium.html\" target=\"_blank\">Vicinium&nbsp;</a>is a recombinant fusion protein designed to specifically target and deliver an anti-cancer payload directly to cancer cells. The company says it is a next-generation ADC by virtue of its targeting of EpCAM antigens on the surface of tumor cells.</li><li>Management will host a conference call at 4:05 pm ET to discuss the results.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3343346-eleven-bio-22-percent-bullish-expectations-late-stage-vicinium-data\" target=\"_blank\">Eleven Bio up 22% on bullish expectations for late-stage Vicinium data</a> (April 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358339\" data-linked=\"Sesen Bio&#39;s lead ADC shows treatment effect in late-stage bladder cancer study\" data-tweet=\"$SESN - Sesen Bio&#39;s lead ADC shows treatment effect in late-stage bladder cancer study https://seekingalpha.com/news/3358339-sesen-bios-lead-adc-shows-treatment-effect-in-late-stage-bladder-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3358339-sesen-bios-lead-adc-shows-treatment-effect-in-late-stage-bladder-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358337\" data-ts=\"1526930645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358337-microchip-tech-commences-senior-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microchip Tech commences senior note offering</a></h4><ul><li>        Microchip Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) <a href=\"https://seekingalpha.com/pr/17169477-microchip-technology-announces-intention-offer-senior-secured-notes-multiple-tranches\" target=\"_blank\">commences</a> an unregistered offering of senior secured notes of multiple tranches.</li><li>               Microchip will use a combo of the net proceeds from the offering, cash on hand, and borrowings to fund its acquisition of Microsemi (NASDAQ:<a href='https://seekingalpha.com/symbol/MSCC' title='Microsemi Corporation'>MSCC</a>). &nbsp;&nbsp;</li><li>               Microchip shares are&nbsp;<font color='green'>up 0.8%</font>&nbsp;to $93.56.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358337\" data-linked=\"Microchip Tech commences senior note offering\" data-tweet=\"$MCHP $MCHP $MSCC - Microchip Tech commences senior note offering https://seekingalpha.com/news/3358337-microchip-tech-commences-senior-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3358337-microchip-tech-commences-senior-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358336\" data-ts=\"1526930272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358336-semiconductors-show-strength-on-micron-guidance-eased-trade-tension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semiconductors show strength on Micron guidance, eased trade tension</a></h4><ul><li>        Semiconductors head towards the close strong on the eased China-US relations and Micron&rsquo;s (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+3.9%</font>) increased guidance.</li><li>               The Philadelphia Semiconductor Index is&nbsp;<font color='green'>up 0.8%</font>.&nbsp;&nbsp;</li><li>        Other movers: Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+1.2%</font>), KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='green'>+1.4%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+2%</font>), and Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='green'>+1.8%</font>).&nbsp;</li><li>Semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3358154-nxp-semiconductors-micron-among-movers-trade-war-hold\" target=\"_blank\">NXP Semiconductors, Micron among movers on trade war hold</a> (May 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-analyst-day-shares-plus-4_1-percent\" target=\"_blank\">Micron raises Q3 guidance ahead of analyst day; shares +4.1%</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358336\" data-linked=\"Semiconductors show strength on Micron guidance, eased trade tension\" data-tweet=\"$MU $MU $INTC - Semiconductors show strength on Micron guidance, eased trade tension https://seekingalpha.com/news/3358336-semiconductors-show-strength-on-micron-guidance-eased-trade-tension?source=tweet\" data-url=\"https://seekingalpha.com/news/3358336-semiconductors-show-strength-on-micron-guidance-eased-trade-tension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358335\" data-ts=\"1526930242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358335-ge-jumps-to-three-month-highs-analysts-praise-wabtec-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE jumps to three-month highs as analysts praise Wabtec deal</a></h4><ul>     <li><a href=\"https://www.cnbc.com/2018/05/21/ge-shares-rise-as-street-praises-its-deal-to-divest-transportation-unit.html\" target=\"_blank\">Analysts are applauding</a> General Electric's (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+2.7%</font>) deal to <a href=\"https://seekingalpha.com/news/3358144-wabtec-ge-transportation-merge\" target=\"_blank\">merge its transportation business</a> with Wabtec (<a href='https://seekingalpha.com/symbol/WAB' title='Westinghouse Air Brake Technologies Corporation'>WAB</a> <font color='green'>+3.9%</font>) in which GE will get $2.9B in cash and&nbsp; 50.1% ownership of the combined  company.</li>     <li>\"This deal is the largest cornerstone for John Flannery's plan  to divest non-core assets,\" William Blair analyst Nick Heymann tells CNBC. \"If this stock starts to move higher, people will worry  about missing the upside.\"</li>     <li>\"GE is no longer a contrarian stock. It's a value stock,\" Heymann says, rating GE at Outperform; while he does not have an  official price target, he thinks shares  can rise to $20-$22 in the next 12 months if the company  generates $10B of annual free cash flow or $1.15 of free cash flow per  share.</li>     <li>\"The removal of this capital-intensive and secularly challenged business  is still a net positive overall for GE's portfolio transformation,\" RBC Capital's Deane Dray writes, adding that \"the $2.9B cash infusion helps give  GE some welcomed cushion for its liquidity needs.\"</li>     <li>&ldquo;Both business units have been impacted by the extreme cyclicality and uneven order flow of the locomotive business, and both units are likely to see improved demand in the next two years coming off a trough in demand in 2017,&rdquo; says CFRA's Jim Corridore, who <a href=\"https://www.marketwatch.com/story/ges-stock-surges-into-bull-market-territory-after-deal-to-merge-transportation-unit-with-wabtec-2018-05-21\" target=\"_blank\">continues to rate GE a Hold</a>.</li>     <li>Wells Fargo's Allison Poliniak-Cusic <a href=\"https://www.barrons.com/articles/ge-wabtec-deal-investors-should-be-on-board-1526915666?mod=hp_RTA\" target=\"_blank\">likes the deal for WAB</a>, \"with GE's locomotive positioning coupled with its increasing focus on digital and analytics being additive to&nbsp;Wabtec's&nbsp;portfolio.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358335\" data-linked=\"GE jumps to three-month highs as analysts praise Wabtec deal\" data-tweet=\"$GE $GE $WAB - GE jumps to three-month highs as analysts praise Wabtec deal https://seekingalpha.com/news/3358335-ge-jumps-to-three-month-highs-analysts-praise-wabtec-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3358335-ge-jumps-to-three-month-highs-analysts-praise-wabtec-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358329\" data-ts=\"1526928994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAVS\" target=\"_blank\">UAVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358329-technology-top-5-gainers-losers-of-2_55-pm-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (05/21/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/UAVS' title='AgEagle'>UAVS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HMI' title='Huami Corporation'>HMI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+8%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/LKM' title='Link Motion Inc.'>LKM</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358329\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (05/21/2018)\" data-tweet=\"$UAVS $UAVS $RESN - Technology - Top 5 Gainers / Losers as of 2.55 PM (05/21/2018) https://seekingalpha.com/news/3358329-technology-top-5-gainers-losers-of-2_55-pm-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358329-technology-top-5-gainers-losers-of-2_55-pm-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358328\" data-ts=\"1526928287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358328-deere-shares-getting-ahead-of-melius-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere shares getting ahead of themselves, Melius analyst says</a></h4><ul>     <li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+2%</font>) enjoys strong gains following China's agreement to <a href=\"https://seekingalpha.com/news/3358166-us-china-trade-talks-yield-farming-deal\" target=\"_blank\">buy \"massive\" amounts</a> of agricultural equipment - although no specifics have been provided - and have jumped 8% since it reported quarterly results <a href=\"https://seekingalpha.com/news/3357998-deere-plus-6-percent-pledge-raise-equipment-prices-fight-rising-costs\" target=\"_blank\">last Friday</a>, but Melius Research thinks DE shares may have gotten ahead of themselves.</li>     <li>Melius's Rob Wertheimer warns the bull case for agriculture, and by extension DE, relies on \"record levels of&nbsp;equipment inefficiency and excess machinery continuing to worsen... we can&rsquo;t see a way to be as sanguine as consensus.\"</li><li>But Wertheimer says farming practices are changing to use less power per acre prepped and planted, as GPS and guidance systems make horsepower more productive.</li><li>The analyst does not see a way to justify DE's big gap with Caterpillar, especially given catalysts at the latter, thus he reiterates a Neutral rating on DE and $164 price target; the firm rates CAT as a Buy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358328\" data-linked=\"Deere shares getting ahead of themselves, Melius analyst says\" data-tweet=\"$DE - Deere shares getting ahead of themselves, Melius analyst says https://seekingalpha.com/news/3358328-deere-shares-getting-ahead-of-melius-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3358328-deere-shares-getting-ahead-of-melius-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358323\" data-ts=\"1526927192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDE\" target=\"_blank\">DDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358323-dover-downs-tracks-back-after-monster-sports-betting-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover Downs tracks back after monster sports betting rally</a></h4><ul> <li>Dover Downs Gaming &amp; Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/DDE' title='Dover Downs Gaming & Entertainment, Inc.'>DDE</a>) is <font color='red'>down 8.72%</font> to cut into last week's monster rally after Delaware moved forward to implement sports betting.</li> <li>Analysts says investors may have bid up Dover Downs too high in relation to the relatively <a href=\"https://delawarestatenews.net/news/expanded-sports-wagering-to-start-in-june/\" target=\"_blank\">narrow margins</a> on single-game sports bets.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3357951-investors-double-dover-downs\" target=\"_blank\">Investors double down on Dover Downs</a> (May 18)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3358323\" data-linked=\"Dover Downs tracks back after monster sports betting rally\" data-tweet=\"$DDE - Dover Downs tracks back after monster sports betting rally https://seekingalpha.com/news/3358323-dover-downs-tracks-back-after-monster-sports-betting-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3358323-dover-downs-tracks-back-after-monster-sports-betting-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358321\" data-ts=\"1526926069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358321-amazon-plans-latin-american-cloud-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon plans Latin American cloud expansion</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://www.reuters.com/article/us-amazon-com-argentina/amazon-eyes-latam-expansion-opens-argentina-office-idUSKCN1IM1VZ?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=Twitter&amp;utm_medium=Social&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">expects to expand</a> its cloud computing operations in Latin America a month after AWS opened an office in Buenos Aires.</li><li>                  Amazon also has offices in Brazil, Chile, Colombia, and Mexico.    </li><li>               The expansion announcement came via a press conference with Teresa Carlson, VP of worldwide public sector.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 0.4%</font>&nbsp;to $1,580.87.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358321\" data-linked=\"Amazon plans Latin American cloud expansion\" data-tweet=\"$AMZN - Amazon plans Latin American cloud expansion https://seekingalpha.com/news/3358321-amazon-plans-latin-american-cloud-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3358321-amazon-plans-latin-american-cloud-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358319\" data-ts=\"1526925622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358319-energy-materials-top-gainers-losers-of-2-00-pm-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/21/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SDR' title='SandRidge Mississippian Trust II'>SDR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+10%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-5%</font>.</li> &nbsp;     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3358319\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/21/2018)\" data-tweet=\"$EGY $EGY $TGA - Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/21/2018) https://seekingalpha.com/news/3358319-energy-materials-top-gainers-losers-of-2-00-pm-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358319-energy-materials-top-gainers-losers-of-2-00-pm-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358318\" data-ts=\"1526924074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358318-celgene-business-development-chief-out-last-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene business development chief out last month</a></h4><ul><li>John Carroll <a href=\"https://endpts.com/bd-chief-george-golumbeski-is-the-latest-top-exec-to-exit-celgene-during-management-overhaul/\" target=\"_blank\">reports </a>that Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-4.3%</font>) business development head George Golumbeski quietly ended his nine-year stint at the biotech last month. His departure, mutually amicable according to Mr. Golumbeski, was the latest in a management shakeup led by new CEO Mark Alles. Former COO Scott Smith left a few days prior.</li><li>Mr. Golumbeski played a leading role a series of major acquisitions, including the $9B Juno buyout. Several acquired candidates have been failures, though, such as IBD drug mongersen and MS med ozanimod.</li><li>Celgene has shed almost half its value since the mongersen flop in October 2017.</li><li>For what it's worth, RBC says the continued weakness in the stock is unfounded considering Mr. Golumbeski was nearing the end of his career at the company and had already transitioned to a strategic role.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302442-celgene-hits-bump-road-ibd-candidate-gedminus-0301-two-studies-terminated-shares-poised-move\" target=\"_blank\">Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours</a> (Oct. 19, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358318\" data-linked=\"Celgene business development chief out last month\" data-tweet=\"$CELG - Celgene business development chief out last month https://seekingalpha.com/news/3358318-celgene-business-development-chief-out-last-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3358318-celgene-business-development-chief-out-last-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358315\" data-ts=\"1526922854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IEP\" target=\"_blank\">IEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358315-icahn-owner-of-dell-technologies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn an owner of Dell Technologies</a></h4><ul><li>Appearing on CNBC, Carl Icahn (NYSE:<a href='https://seekingalpha.com/symbol/IEP' title='Icahn Enterprises L.P.'>IEP</a>) says he own shares of Dell Technologies (DVMT), and hopes Dell would pay the right price should it choose to purchase the rest of VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346331-cnbc-icahn-takes-medium-stake-vmware\" target=\"_blank\">CNBC: Icahn takes 'medium' stake in VMware</a> (April 18)</li><li>Dell jumped by a couple of percent on the Icahn mention, but has since settled back to&nbsp;<font color='green'>up 0.75%</font>&nbsp;on the session. VMW<font color='red'> -0.5%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3358315\" data-linked=\"Icahn an owner of Dell Technologies\" data-tweet=\"$IEP $IEP $DELL - Icahn an owner of Dell Technologies https://seekingalpha.com/news/3358315-icahn-owner-of-dell-technologies?source=tweet\" data-url=\"https://seekingalpha.com/news/3358315-icahn-owner-of-dell-technologies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358314\" data-ts=\"1526922386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBFI\" target=\"_blank\">MBFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358314-financials-top-gainers-losers-of-1-05-pm-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:05 PM (05/21/2018)</a></h4><ul><li><strong>Top Gainers:</strong>&nbsp;<a href='https://seekingalpha.com/symbol/MBFI' title='MB Financial Inc.'>MBFI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/INBK' title='First Internet Bancorp'>INBK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CMFN' title='CM Finance'>CMFN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='green'>+6%</font>.</li><li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358314\" data-linked=\"Financials - Top Gainers / Losers as of 1:05 PM (05/21/2018)\" data-tweet=\"$MBFI $MBFI $GNW - Financials - Top Gainers / Losers as of 1:05 PM (05/21/2018) https://seekingalpha.com/news/3358314-financials-top-gainers-losers-of-1-05-pm-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358314-financials-top-gainers-losers-of-1-05-pm-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358311\" data-ts=\"1526921706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358311-spirit-airlines-higher-amid-report-of-fare-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit Airlines higher amid report of fare hike</a></h4><ul><li>Spirits Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a>) is&nbsp;<font color='green'>up 2.85%</font>&nbsp;after JPMorgan tips that the company has raised domestic fares.</li><li>The second part of the equation will be if other airlines match the fare hike on competing routes.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3358311\" data-linked=\"Spirit Airlines higher amid report of fare hike\" data-tweet=\"$SAVE - Spirit Airlines higher amid report of fare hike https://seekingalpha.com/news/3358311-spirit-airlines-higher-amid-report-of-fare-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3358311-spirit-airlines-higher-amid-report-of-fare-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358306\" data-ts=\"1526920849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADOM\" target=\"_blank\">ADOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358306-midday-gainers-losers-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (05/21/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+50%</font>. <a href='https://seekingalpha.com/symbol/ARTW' title='Art&#39;s-Way Manufacturing Co., Inc.'>ARTW</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/ENT' title='Global Eagle Entertainment, Inc.'>ENT</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/UAVS' title='AgEagle'>UAVS</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MBFI' title='MB Financial Inc.'>MBFI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+13%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LIVX' title='LiveXLive Media, Inc.'>LIVX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics'>NBRV</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MOTS' title='Motus GI Holdings'>MOTS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a> <font color='red'>-10%</font>.</li> &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3358306\" data-linked=\"Midday Gainers / Losers (05/21/2018)\" data-tweet=\"$ADOM $ADOM $ARTW - Midday Gainers / Losers (05/21/2018) https://seekingalpha.com/news/3358306-midday-gainers-losers-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358306-midday-gainers-losers-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358304\" data-ts=\"1526920771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358304-inovio-launches-mid-stage-study-of-vgxminus-3100-in-anal-precancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio launches mid-stage study of VGX-3100 in anal precancer</a></h4><ul><li>Inovio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='red'>-3%</font>) <a href=\"https://seekingalpha.com/pr/17168945-inovio-opens-phase-2-trial-vgxminus-3100-third-indication-treat-hpv-1-sexually-transmitted\" target=\"_blank\">commences </a>a Phase 2 clinical trial evaluating lead candidate VGX-3100 in adults men and women with human papillomavirus &#40;HPV&#41;-related anal dysplasia (the presence of abnormal cells that could develop into anal cancer).</li><li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT03499795?term=NCT03499795&amp;rank=1\" target=\"_blank\">open-label study</a> will enroll ~24 subjects who will receive at least three doses of VGX-3100. According to ClinicalTrials.gov, the estimated completion date is August 2020.</li><li>Anal cancer kills 1,100 Americans each year. The current standard of care for anal dysplasia is surgical excision, electrocautery or laser therapy. The post-treatment recurrence rate is greater than 50%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358304\" data-linked=\"Inovio launches mid-stage study of VGX-3100 in anal precancer\" data-tweet=\"$INO - Inovio launches mid-stage study of VGX-3100 in anal precancer https://seekingalpha.com/news/3358304-inovio-launches-mid-stage-study-of-vgxminus-3100-in-anal-precancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3358304-inovio-launches-mid-stage-study-of-vgxminus-3100-in-anal-precancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358305\" data-ts=\"1526920753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWE\" target=\"_blank\">WWE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358305-wweplus-4_7-on-report-of-massive-fox-offer-for-smackdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WWE +4.7% on report of &#39;massive&#39; Fox offer for &#39;SmackDown&#39;</a></h4><ul>   <li>World Wrestling Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/WWE' title='World Wrestling Entertainment, Inc.'>WWE</a>) has <font color='green'>jumped 4.7%</font> after receiving a \"massive\" offer to make Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) the <a href=\"http://www.espn.com/wwe/story/_/id/23562745/fox-reaches-agreement-air-wwe-smackdown-live\" target=\"_blank\">new home of <i>SmackDown Live,</i></a> ESPN reports.</li>    <li>Specific terms weren't known but the deal is set to begin in October 2019.</li>    <li>That news comes after NBCUniversal (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) declined first refusal on <i>SmackDown,</i> choosing instead to focus on <i>Monday Night Raw.</i></li>    <li><i>SmackDown Live</i> has averaged 2.59M viewers/week this year, while <i>Raw</i> has averaged about 3M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358305\" data-linked=\"WWE +4.7% on report of &#39;massive&#39; Fox offer for &#39;SmackDown&#39;\" data-tweet=\"$WWE $WWE $FOX - WWE +4.7% on report of &#39;massive&#39; Fox offer for &#39;SmackDown&#39; https://seekingalpha.com/news/3358305-wweplus-4_7-on-report-of-massive-fox-offer-for-smackdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3358305-wweplus-4_7-on-report-of-massive-fox-offer-for-smackdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358302\" data-ts=\"1526920250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNET\" target=\"_blank\">VNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358302-chinas-21vianet-to-two-month-high-on-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China&#39;s 21Vianet to two-month high on volume</a></h4><ul>   <li>China's 21Vianet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a>) is <font color='green'>up 11.6%</font> on heavy volume in a delayed move after Thursday's earnings report.</li>    <li>Shares are at their highest point since March 23. They're now <font color='red'>down just 16%</font> YTD.</li>    <li>On Thursday, the company <a href=\"https://seekingalpha.com/news/3357789-21vianet-group-reports-q1-results\" target=\"_blank\">reported EBITDA nearly doubled</a> to 196M yuan, with EBITDA margin jumping to 24.5% from the prior year's 11.6%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358302\" data-linked=\"China&#39;s 21Vianet to two-month high on volume\" data-tweet=\"$VNET - China&#39;s 21Vianet to two-month high on volume https://seekingalpha.com/news/3358302-chinas-21vianet-to-two-month-high-on-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3358302-chinas-21vianet-to-two-month-high-on-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358299\" data-ts=\"1526920176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNW\" target=\"_blank\">FTNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358299-fte-networks-up-5-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTE Networks up 5% post Q1 results</a></h4><ul><li>FTE Networks      (<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a> <font color='green'>+5%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4032962\" target=\"_blank\">reports Q1</a>&nbsp;revenue      growth of 89.1% Y/Y to $85.1M.</li><li>Q1 overall margins: Gross&nbsp;<font color='red'>declined 700 bps</font>&nbsp;to 15.2% &amp; Adj. EBITDA&nbsp;<font color='green'>increased 626 bps</font>&nbsp;to 8.7%.</li><li>Operating expenses were $11.3M      (+22.8% Y/Y), the increase in expenses was due to higher stock      compensation expense &amp; increased amortization expense of intangible      assets.</li><li>The company announced new      infrastructure &amp; technology expansion projects valued at ~$161M YTD.</li><li>Also, entered into agreement with a global tier-1 commercial real estate      owner to provide CrossLayer service for their in-building technology &amp;      technology solutions.</li><li>Achieved a combined backlog of ~$460.7M      (+6.2% Y/Y).</li><li>Cash &amp; equivalents of $9.6M &amp;      working capital of $12.5M.</li><li><b>2018 Outlook: </b>Net revenue of $350M; Adj. EBITDA of $30M; Operating      Income of $15M &amp; Buildings on-net, 30.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358192-fte-networks-reports-q1-results\" target=\"_blank\">FTE Networks reports Q1 results</a> (May 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358299\" data-linked=\"FTE Networks up 5% post Q1 results\" data-tweet=\"$FTNW - FTE Networks up 5% post Q1 results https://seekingalpha.com/news/3358299-fte-networks-up-5-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3358299-fte-networks-up-5-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358297\" data-ts=\"1526919339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADOM\" target=\"_blank\">ADOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358297-consumer-top-gainers-losers-of-12-15-pm-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:15 PM (05/21/2018)</a></h4><ul><li><strong>Top Gainers:</strong> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ENR' title='Energizer Holdings, Inc.'>ENR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+5%</font>.</li><li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358297\" data-linked=\"Consumer - Top Gainers / Losers as of 12:15 PM (05/21/2018)\" data-tweet=\"$ADOM $ADOM $FUV - Consumer - Top Gainers / Losers as of 12:15 PM (05/21/2018) https://seekingalpha.com/news/3358297-consumer-top-gainers-losers-of-12-15-pm-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358297-consumer-top-gainers-losers-of-12-15-pm-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358296\" data-ts=\"1526919323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCSC\" target=\"_blank\">FCSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358296-fibrocells-gene-therapy-fcxminus-007-shows-positive-effect-in-rdeb-study-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fibrocell&#39;s gene therapy FCX-007 shows positive effect in RDEB study; shares up 4%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17168793-fibrocell-reports-interim-results-progress-phase-1-2-clinical-trial-fcxminus-007-gene-therapy\" target=\"_blank\">Preliminary data</a> from a Phase 1/2 study evaluating Fibrocell Science's (<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+3.7%</font>) gene therapy, FCX-007, in patients with recessive dystrophic epidermolysis bullosa &#40;RDEB&#41; showed a treatment effect. The data were presented at the International Investigative Dermatology Conference in Washington, D.C.</li><li>Four patients with a total of seven wounds that were open for up to eight months prior to treatment were dosed with FCX-007 in the margins and across wounds in addition to intact skin sites.</li><li>At week 4, 100% (n=7/7) of wounds healed at least 50% compared to only one untreated wound (n=1/7). The treatment effect was durable, with 86% and 67%, respectively, of wounds maintaining the response at weeks 12 and 25/32.</li><li>Enrollment of six patients in the Phase 2 portion should be completed next quarter.</li><li>The company is developing FCX-007 in collaboration with Intrexon's Precigen unit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358296\" data-linked=\"Fibrocell&#39;s gene therapy FCX-007 shows positive effect in RDEB study; shares up 4%\" data-tweet=\"$FCSC - Fibrocell&#39;s gene therapy FCX-007 shows positive effect in RDEB study; shares up 4% https://seekingalpha.com/news/3358296-fibrocells-gene-therapy-fcxminus-007-shows-positive-effect-in-rdeb-study-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3358296-fibrocells-gene-therapy-fcxminus-007-shows-positive-effect-in-rdeb-study-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358293\" data-ts=\"1526918373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358293-italian-bonds-routed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Italian bonds routed</a></h4><ul><li>The supposedly bullish news<a href=\"https://seekingalpha.com/news/3358113-power-sharing-agreement-italy\" target=\"_blank\"> of a power-sharing agreement </a>between Italy's Five Star Movement and The League isn't doing much to help that country's market for government debt, and chatter about a eurozone break up is again entering the conversation.</li><li>Italy's 10-year government bond has exploded higher by 18 basis points today to 2.40%. Against Germany, it looks even worse, as 10-year Bund yields are down six basis points.</li><li>Italian stocks are the worst performers on the Continent as well, with the FTSE MIB&nbsp;<font color='red'>down 1.5%</font>&nbsp;vs. the Stoxx 600's&nbsp;<font color='green'>0.3% advance</font>.</li><li>Checking another peripheral name, Spanish 10-year yields are up 7.5 basis points to 1.50%, and the IBEX 35 is<font color='red'> off 0.45%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWP' title='iShares MSCI Spain Capped ETF'>EWP</a>, <a href='https://seekingalpha.com/symbol/EWI' title='iShares MSCI Italy Capped ETF'>EWI</a>, <a href='https://seekingalpha.com/symbol/HEWI' title='iShares Currency Hedged MSCI Italy ETF'>HEWI</a>, <a href='https://seekingalpha.com/symbol/HEWP' title='iShares Currency Hedged MSCI Spain ETF'>HEWP</a>, <a href='https://seekingalpha.com/symbol/DBSP' title='Deutsche X-trackers MSCI Spain Hedged Equity ETF'>DBSP</a>, <a href='https://seekingalpha.com/symbol/DBIT' title='Deutsche X-trackers MSCI Italy Hedged Equity ETF'>DBIT</a>, <a href='https://seekingalpha.com/symbol/FLIY' title='Franklin FTSE Italy ETF'>FLIY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3358293\" data-linked=\"Italian bonds routed\" data-tweet=\"$EWP $EWI $HEWI - Italian bonds routed https://seekingalpha.com/news/3358293-italian-bonds-routed?source=tweet\" data-url=\"https://seekingalpha.com/news/3358293-italian-bonds-routed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358289\" data-ts=\"1526917975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNT\" target=\"_blank\">SSNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358289-silversun-technologies-acquires-info-sys-management\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SilverSun Technologies acquires Info Sys Management</a></h4><ul>     <li>SilverSun Technologies's (<a href='https://seekingalpha.com/symbol/SSNT' title='SilverSun Technologies, Inc.'>SSNT</a> <font color='green'>+7%</font>) subsidiary (SWK Technologies) has acquired  Info Sys Management for $1.7M. The deal will be effective June 1, 2018.</li>     <li>Info Sys Management is reseller of Sage Software and Acumatica  solutions, also provides hosting services for business applications to customers throughout the United States. The company currently has offices in Portland, San Diego, Phoenix and Washington, D.C.</li>     <li><a href=\"https://seekingalpha.com/pr/17169006-silversun-technologies-acquires-info-sys-management-inc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3358289\" data-linked=\"SilverSun Technologies acquires Info Sys Management\" data-tweet=\"$SSNT - SilverSun Technologies acquires Info Sys Management https://seekingalpha.com/news/3358289-silversun-technologies-acquires-info-sys-management?source=tweet\" data-url=\"https://seekingalpha.com/news/3358289-silversun-technologies-acquires-info-sys-management\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358288\" data-ts=\"1526917933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358288-piper-jaffray-raises-splunk-target-to-11-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray raises its Splunk target to 11% upside</a></h4><ul><li>        Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Splunk+%28SPLK%29+PT+Raised+to+%24130+at+Piper+Jaffray/14216374.html\" target=\"_blank\">raises</a> its Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) price target from $115 to $130.</li><li>               Rating maintained at Overweight, an 11% upside to Friday&rsquo;s close</li><li>                  Splunk shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;to $115.26. <br />&nbsp;   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358288\" data-linked=\"Piper Jaffray raises its Splunk target to 11% upside\" data-tweet=\"$SPLK - Piper Jaffray raises its Splunk target to 11% upside https://seekingalpha.com/news/3358288-piper-jaffray-raises-splunk-target-to-11-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3358288-piper-jaffray-raises-splunk-target-to-11-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358285\" data-ts=\"1526917649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358285-analyst-raises-workdays-target-to-12-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst raises Workday&#39;s target to 12% upside</a></h4><ul><li>           Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Workday+%28WDAY%29+PT+Raised+to+%24150+at+Piper+Jaffray/14216373.html\" target=\"_blank\">raises</a> its Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) price target from $140 to $150. </li><li> Rating maintained at Overweight, a 12% upside to Friday&rsquo;s close. </li><li> Workday shares are&nbsp;<font color='red'>down 1.9%</font>. &nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3358285\" data-linked=\"Analyst raises Workday&#39;s target to 12% upside\" data-tweet=\"$WDAY - Analyst raises Workday&#39;s target to 12% upside https://seekingalpha.com/news/3358285-analyst-raises-workdays-target-to-12-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3358285-analyst-raises-workdays-target-to-12-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358283\" data-ts=\"1526917468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358283-fda-oks-dova-pharmas-avatrombopag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK&#39;s Dova Pharma&#39;s avatrombopag</a></h4><ul><li>Dova Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a> <font color='red'>-7.1%</font>) is set for an up move on the news that the FDA has <a href=\"https://www.reuters.com/article/dova-pharms-fda/fda-approves-dova-pharmas-blood-disorder-drug-idUSL3N1SS4H9\" target=\"_blank\">approved </a>avatrombopag for thrombocytopenia (low blood platelets) in patients with chronic liver disease.</li><li>Trading is currently suspended.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314580-fda-accepts-dova-pharmas-marketing-application-avatrombopag-thrombocytopenia-action-date-may\" target=\"_blank\">FDA accepts Dova Pharma's marketing application for avatrombopag for thrombocytopenia, action date May 21, 2018; shares ahead 1% after hours</a> (Nov. 27, 2017)</li><li><strong>Update</strong>: Shares will resume trading at 1:15 pm ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358283\" data-linked=\"FDA OK&#39;s Dova Pharma&#39;s avatrombopag\" data-tweet=\"$DOVA - FDA OK&#39;s Dova Pharma&#39;s avatrombopag https://seekingalpha.com/news/3358283-fda-oks-dova-pharmas-avatrombopag?source=tweet\" data-url=\"https://seekingalpha.com/news/3358283-fda-oks-dova-pharmas-avatrombopag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358282\" data-ts=\"1526917226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358282-gogominus-3_2-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo -3.2% on analyst downgrade</a></h4><ul><li>        UBS <a href=\"https://www.streetinsider.com/Downgrades/UBS+Downgrades+Gogo+%28GOGO%29+to+Neutral/14217322.html\" target=\"_blank\">downgrades</a> Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) from Buy to Neutral.</li><li>               Gogo shares are&nbsp;<font color='red'>down 3.2%</font>&nbsp;to $5.12.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358282\" data-linked=\"Gogo -3.2% on analyst downgrade\" data-tweet=\"$GOGO - Gogo -3.2% on analyst downgrade https://seekingalpha.com/news/3358282-gogominus-3_2-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3358282-gogominus-3_2-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358281\" data-ts=\"1526917160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358281-mabvax-down-27-on-accuracy-issues-in-prior-financials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax down 27% on accuracy issues in prior financials</a></h4><ul><li>Thinly traded nano cap MabVax Therapeutics Holdings (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-26.6%</font>) slumps on almost double normal volume, albeit on turnover of only 168K shares, in apparent response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1109196/000165495418005675/mbvx8k_may212018.htm\" target=\"_blank\">disclosure </a>that its financial statements for the years 2014 - 2017 can no longer be relied upon.</li><li>The issue apparently relates to the ownership of preferred stock and whether certain investors acted as an undisclosed group in acquiring shares.</li><li>The company has notified the SEC that it will be late in filing its Q1 financial statements while the matter is investigated.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326358-sec-investigating-mabvax-related-registration-statements\" target=\"_blank\">SEC investigating MabVax related to registration statements</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358281\" data-linked=\"MabVax down 27% on accuracy issues in prior financials\" data-tweet=\"$MBVX $MBVXQ - MabVax down 27% on accuracy issues in prior financials https://seekingalpha.com/news/3358281-mabvax-down-27-on-accuracy-issues-in-prior-financials?source=tweet\" data-url=\"https://seekingalpha.com/news/3358281-mabvax-down-27-on-accuracy-issues-in-prior-financials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358280\" data-ts=\"1526916888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGN\" target=\"_blank\">EGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358280-energenplus-3-icahn-corvex-consider-making-takeover-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energen +3% as Icahn, Corvex consider making takeover offer</a></h4><ul>     <li>Carl Icahn and Corvex Management hedge fund, run by former Icahn Capital executive Keith Meister, declare a <a href=\"https://www.oilandgasinvestor.com/corvex-carl-icahn-mull-takeover-bid-energen-1702596#p=full\" target=\"_blank\">potential desire to buy</a> Energen (<a href='https://seekingalpha.com/symbol/EGN' title='Energen Corporation'>EGN</a> <font color='green'>+2.9%</font>), according to an <a href=\"https://www.sec.gov/Archives/edgar/data/277595/000119312518168728/d563755dsc13da.htm\" target=\"_blank\">SEC filing</a>.</li>     <li>Meister and Icahn and Meister say EGN's shares are undervalued and may seek to join other parties in acquiring the oil and gas producer.</li>     <li>The filing also says Corvex sold 2M&nbsp;EGN shares to Icahn for $64.84/share and granted him an option to buy another 2M shares for $67.37/share.</li>     <li>Icahn&rsquo;s affiliates could own ~4.1% of EGN, or a combined 4M shares, according to the filing; Corvex would continue to own 8.7%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358280\" data-linked=\"Energen +3% as Icahn, Corvex consider making takeover offer\" data-tweet=\"$EGN - Energen +3% as Icahn, Corvex consider making takeover offer https://seekingalpha.com/news/3358280-energenplus-3-icahn-corvex-consider-making-takeover-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3358280-energenplus-3-icahn-corvex-consider-making-takeover-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358277\" data-ts=\"1526916158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOK\" target=\"_blank\">MYOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358277-myokardia-finalizes-design-of-late-stage-study-of-mavacamten-in-ohcm-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MyoKardia finalizes design of late-stage study of mavacamten in oHCM; shares down 9%</a></h4><ul><li>MyoKardia (<a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a> <font color='red'>-9%</font>) <a href=\"https://seekingalpha.com/pr/17168848-myokardia-announces-design-phase-3-explorer-hcm-study-evaluating-mavacamten-symptomatic\" target=\"_blank\">announces</a> the design of its Phase 3 EXPLORER-HCM study assessing mavacamten in patients with symptomatic <a href=\"http://www.heart.org/HEARTORG/Conditions/More/Cardiomyopathy/Hypertrophic-Cardiomyopathy_UCM_444317_Article.jsp#.WwLgxUgvxhE\" target=\"_blank\">obstructive&nbsp;hypertrophic cardiomyopathy</a> (oHCM), disorder of the heart characterized impaired pumping performance caused by thickening in the ventricular walls.</li><li>The randomized double-blind trial will evaluate mavacamten over a 30-week treatment period in 220 subjects. The primary endpoint will be the clinical response rate versus placebo.</li><li>Dosing should start this quarter with topline results expected in H2 2020. Investors appear disappointed with the timeline, including the treatment period, almost twice as long as the 16-weeks used in Phase 2.</li><li>Mavacamten is an orally available small molecule designed to reduce left ventricular contractility by modulating the function of cardiac myosin, the protein that drives heart muscle contraction.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342995-myokardia-commences-mid-stage-study-mavacantem-non-obstructive-hcm\" target=\"_blank\">MyoKardia commences mid-stage study of mavacantem in non-obstructive HCM</a> (April 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358277\" data-linked=\"MyoKardia finalizes design of late-stage study of mavacamten in oHCM; shares down 9%\" data-tweet=\"$MYOK - MyoKardia finalizes design of late-stage study of mavacamten in oHCM; shares down 9% https://seekingalpha.com/news/3358277-myokardia-finalizes-design-of-late-stage-study-of-mavacamten-in-ohcm-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3358277-myokardia-finalizes-design-of-late-stage-study-of-mavacamten-in-ohcm-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358278\" data-ts=\"1526915881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHLR\" target=\"_blank\">WHLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358278-activist-reports-7_2-stake-in-wheeler-reit-threatens-legal-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist reports 7.2% stake in Wheeler REIT, threatens legal action</a></h4><ul><li>Wheeler REIT (<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-0.7%</font>) has failed <a href=\"https://seekingalpha.com/filing/4033094\" target=\"_blank\">to maintain asset coverage</a> as required by the Asset Coverage Provision, according to James Pappas' JCP Investment.</li><li>JCP is threatening legal action if not cured by June 8.</li><li>Wheeler earlier this month did file a Certificate of Correction to the Asset Coverage Provision, but JCP believes this to be invalid.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358278\" data-linked=\"Activist reports 7.2% stake in Wheeler REIT, threatens legal action\" data-tweet=\"$WHLR - Activist reports 7.2% stake in Wheeler REIT, threatens legal action https://seekingalpha.com/news/3358278-activist-reports-7_2-stake-in-wheeler-reit-threatens-legal-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3358278-activist-reports-7_2-stake-in-wheeler-reit-threatens-legal-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358273\" data-ts=\"1526915628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMI\" target=\"_blank\">HMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358273-huami-corporation-up-10-post-q1-result-beats-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huami Corporation up 10% post Q1 result, beats guidance</a></h4><div><ul><li>Huami Corporation (<a href='https://seekingalpha.com/symbol/HMI' title='Huami Corporation'>HMI</a>&nbsp;<font color='green'>+10.3%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17168724-huami-corporation-reports-first-quarter-2018-unaudited-financial-results\" target=\"_blank\">reports Q1</a>&nbsp;revenue growth of 77% Y/Y to RMB585.9M, increase was due to an increase in the shipments of both Xiaomi wearable products &amp; self-branded products.</li><li>Gross margin&nbsp;<font color='green'>increased 270 bps</font>&nbsp;to 25.0%; the increase was driven by improved economies of scale &amp; the rapid growth in sales of self-branded products. Whereas, operating margin marginally&nbsp;<font color='red'>declined&nbsp;13 bps</font>&nbsp;to 1.5%.</li><li>Q1 overall expenses:<b>&nbsp;</b>Total operating were RMB137.8M (+73.6% Y/Y); R&amp;D of RMB73.8M (+82.3% Y/Y); G&amp;A of RMB49.3M (+72.9% Y/Y); S&amp;M of RMB14.7M (+41.8% Y/Y), the expenses were up due to an increase in SBC expenses, excluding it the total operating expenses remained steady with Q1 2017.</li><li>Total units      shipped were 4.8M (+50% Y/Y).</li><li>Cash &amp;      equivalents of RMB1,117.7M (+205% Q/Q).</li><li><b>Q2 Outlook: </b>Net revenues of RMB650-675M, which would represent an      increase of ~32.4%-37.4% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358124-huami-reports-q1-results\" target=\"_blank\">Huami reports Q1 results</a> (May 21)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3358273\" data-linked=\"Huami Corporation up 10% post Q1 result, beats guidance\" data-tweet=\"$HMI - Huami Corporation up 10% post Q1 result, beats guidance https://seekingalpha.com/news/3358273-huami-corporation-up-10-post-q1-result-beats-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3358273-huami-corporation-up-10-post-q1-result-beats-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358272\" data-ts=\"1526915191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOS\" target=\"_blank\">KOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358272-kosmos-to-re-drill-well-off-suriname-after-stability-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kosmos to re-drill well off Suriname after &#39;stability issues&#39;</a></h4><ul>     <li>Kosmos Energy (<a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color='red'>-5.7%</font>)&nbsp;plunges after saying it encountered problems while drilling a well offshore Suriname and <a href=\"https://seekingalpha.com/pr/17168687-kosmos-energy-provides-suriname-activity-update\" target=\"_blank\">would need to start again</a>.</li>     <li>KOS says the Anapai-1 well in Block 45 \"encountered shallow bore hole stability issues before reaching the target interval,\" and it must now re-spud the well, which will require 50-60 days with results expected early in Q3; KOS says its share of the costs incurred to date on drilling the Anapai well totals ~$20M.</li>     <li>KOS is the exploration operator of Block 45 and a 50-50 partner with Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='green'>+0.9%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358272\" data-linked=\"Kosmos to re-drill well off Suriname after &#39;stability issues&#39;\" data-tweet=\"$KOS $KOS $CVX - Kosmos to re-drill well off Suriname after &#39;stability issues&#39; https://seekingalpha.com/news/3358272-kosmos-to-re-drill-well-off-suriname-after-stability-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3358272-kosmos-to-re-drill-well-off-suriname-after-stability-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358270\" data-ts=\"1526914877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358270-fda-clears-xtant-medicals-intice-c-spinal-implant-shares-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Xtant Medical&#39;s InTice-C spinal implant; shares up 24%</a></h4><ul><li>The FDA <a href=\"http://investor.xtantmedical.com/phoenix.zhtml?c=234008&amp;p=irol-newsArticle&amp;id=2349978\" target=\"_blank\">grants 510(k) clearance</a> for Xtant Medical Holdings' (<a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+24.4%</font>) InTice-C Porous Titanium Cervical Interbody System for spinal fusion procedures. The company says its titanium scaffold improves implant fixation and offers multiple footprint, height and endplate options.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358270\" data-linked=\"FDA clears Xtant Medical&#39;s InTice-C spinal implant; shares up 24%\" data-tweet=\"$XTNT - FDA clears Xtant Medical&#39;s InTice-C spinal implant; shares up 24% https://seekingalpha.com/news/3358270-fda-clears-xtant-medicals-intice-c-spinal-implant-shares-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3358270-fda-clears-xtant-medicals-intice-c-spinal-implant-shares-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358269\" data-ts=\"1526914805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SECO\" target=\"_blank\">SECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358269-on-secoo-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Secoo Q4 beat</a></h4><ul><li>Secoo (<a href='https://seekingalpha.com/symbol/SECO' title='Secoo Holding'>SECO</a> <font color='green'>+1.9%</font>) reports top line growth of 60.5% in <a href=\"https://seekingalpha.com/pr/17109265-secoo-reports-unaudited-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>, primarily driven by an increase in the total number of orders and merchandise sales.</li><li>GMV grew 43.9% to RMB1.94B.</li><li>Total number of orders expanded 57.6% to 549.4K.</li><li>Number of active customers increased 66.3% to 0.2M.</li><li>Gross margin improved 30 bps to 15.5%.</li><li>The company expects Q1 total net revenues to be between RMB760M and RMB775M (~+35% to +38%).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340926-secoo-beats-0_15-beats-revenue\" target=\"_blank\">Secoo beats by $0.15, beats on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358269\" data-linked=\"More on Secoo Q4 beat\" data-tweet=\"$SECO - More on Secoo Q4 beat https://seekingalpha.com/news/3358269-on-secoo-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3358269-on-secoo-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358268\" data-ts=\"1526914684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358268-baidu-will-divest-global-ad-tools-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu will divest global ad tools business</a></h4><ul><li>        Baidu (NASDAQ:<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a>) <a href=\"https://seekingalpha.com/pr/17169029-baidu-enters-definitive-agreements-divest-global-du-business\" target=\"_blank\">announces</a> it will divest its global ad and tools business Global DU business.</li><li>               After the completion of the transaction, Baidu will own about 34% of Global DU&rsquo;s outstanding shares and won&rsquo;t have effective control.&nbsp;</li><li>               The transaction is expected to close in Q3. &nbsp;&nbsp;</li><li>               Baidu shares are&nbsp;<font color='red'>down 5.1%</font>&nbsp;to $240.11.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358268\" data-linked=\"Baidu will divest global ad tools business\" data-tweet=\"$BIDU - Baidu will divest global ad tools business https://seekingalpha.com/news/3358268-baidu-will-divest-global-ad-tools-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3358268-baidu-will-divest-global-ad-tools-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358267\" data-ts=\"1526914239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEVPF\" target=\"_blank\">NEVPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358267-neurovives-kl1333-shows-encouraging-action-in-early-stage-study-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroVive&#39;s KL1333 shows encouraging action in early-stage study; shares up 11%</a></h4><ul><li>NeuroVive Pharmaceutical AB (<a href='https://seekingalpha.com/symbol/NEVPF' title='Neurovive Pharmaceutical AB'>OTCQX:NEVPF</a> <font color='green'>+10.9%</font>) and collaboration partner Yungjin Pharm Corp. <a href=\"https://seekingalpha.com/pr/17168720-neurovive-yungjin-reports-positive-kl1333-phase-clinical-study-results-paving-way-clinical\" target=\"_blank\">announce</a> positive results from a Phase 1 ascending dose clinical trial assessing mitochondrial disease candidate KL1333 in healthy volunteers.</li><li>KL1333, a modulator of cellular levels of a coenzyme called <a href=\"https://www.elysiumhealth.com/nad-science-aging-research\" target=\"_blank\">NAD+</a> (nicotinamide adenine dinucleotide), demonstrated a clear dose-proportional pharmacokinetic profile with no serious adverse events. Mild GI distress was observed at the higher doses.</li><li>Next up is a Phase 1 study evaluating repeated dosing in healthy volunteers, expected to start in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358267\" data-linked=\"NeuroVive&#39;s KL1333 shows encouraging action in early-stage study; shares up 11%\" data-tweet=\"$NEVPF - NeuroVive&#39;s KL1333 shows encouraging action in early-stage study; shares up 11% https://seekingalpha.com/news/3358267-neurovives-kl1333-shows-encouraging-action-in-early-stage-study-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3358267-neurovives-kl1333-shows-encouraging-action-in-early-stage-study-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358258\" data-ts=\"1526912884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALLVF\" target=\"_blank\">ALLVF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358258-altice-declines-msci-pulls-from-indexes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice declines as MSCI pulls it from indexes</a></h4><ul>   <li>Altice (<a href='https://seekingalpha.com/symbol/ALLVF' title='Altice Europe N V'>OTCPK:ALLVF</a>) is <font color='red'>off 1.8%</font> in U.S. trading after word from MSCI that it will delete Altice A shares from its global standard and large-cap indexes.</li>    <li>The move is effective May 22, the day the stock goes ex-dividend for a separation of Altice USA (<a href=\"http://seekingalpha.com/symbol/ATUS\" target=\"_blank\">ATUS</a> <font color='red'>-3.3%</font>), where Altice shareholders will get 0.4163 share of Altice USA for each share of Altice held.</li>    <li>Shares of Altice Class A are <font color='red'>down 7.8%</font> in Amsterdam.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358258\" data-linked=\"Altice declines as MSCI pulls it from indexes\" data-tweet=\"$ALLVF $ALLVF $ATUS - Altice declines as MSCI pulls it from indexes https://seekingalpha.com/news/3358258-altice-declines-msci-pulls-from-indexes?source=tweet\" data-url=\"https://seekingalpha.com/news/3358258-altice-declines-msci-pulls-from-indexes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358257\" data-ts=\"1526912736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHU\" target=\"_blank\">SOHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358257-sohu-com-ceo-adds-30k-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sohu.com CEO adds 30K shares</a></h4><ul><li>        Sohu.com (NASDAQ:<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Limited'>SOHU</a>) CEO Charles Zhang <a href=\"https://seekingalpha.com/filing/4033060\" target=\"_blank\">adds 30K shares</a> for a total transaction value of $1.1M.</li><li>               Sohu.com shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $36.83. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3357350-sohu-com-ceo-acquires-16_5k-shares\" target=\"_blank\">Sohu.com CEO acquires 16.5K shares</a> (May 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358257\" data-linked=\"Sohu.com CEO adds 30K shares\" data-tweet=\"$SOHU - Sohu.com CEO adds 30K shares https://seekingalpha.com/news/3358257-sohu-com-ceo-adds-30k-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3358257-sohu-com-ceo-adds-30k-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358251\" data-ts=\"1526912020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358251-snapplus-3_6-bearish-analyst-backs-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +3.6% as bearish analyst backs off</a></h4><ul>   <li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) is <font color='green'>up 3.6%</font> after bearish Michael Nathanson upgrades to Neutral.</li>    <li>\"Life as a public company has been nothing short of an unmitigated disaster,\" he writes, but that's now priced into the stock, after it's dropped 47% since he started his Sell rating 14 months ago.</li>    <li>He's raised his price target to $9 from $7, suggesting downside now is just 18%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358251\" data-linked=\"Snap +3.6% as bearish analyst backs off\" data-tweet=\"$SNAP - Snap +3.6% as bearish analyst backs off https://seekingalpha.com/news/3358251-snapplus-3_6-bearish-analyst-backs-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3358251-snapplus-3_6-bearish-analyst-backs-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358242\" data-ts=\"1526911480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STG\" target=\"_blank\">STG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358242-sunlands-online-education-down-4-despite-strong-q1-result\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunlands Online Education down 4% despite strong Q1 result</a></h4><ul><li>Sunlands Online Education (<a href='https://seekingalpha.com/symbol/STG' title='Sunlands Online Education'>STG</a> <font color='red'>-4.1%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4032857\" target=\"_blank\">reports Q1</a>&nbsp;revenue growth of 161.1% Y/Y to RMB406.37M, the increase was mainly driven by the      growth in gross billings, which was attributable to an increase in new      student enrollments.</li><li>Adj. gross billings were RMB929.2M (+125.5% Y/Y); New student enrollments were      152,140 (+128.6% Y/Y).</li><li>Gross      profit increased by 146.4% Y/Y to RMB335.7M, but margin&nbsp;<font color='red'>declined by 492 bps</font>&nbsp;to 82.61%.</li><li>Adj. EBIDTA was &ndash;RMB247.4M      from &ndash;RMB98.8M Y/Y; Deferred revenue was RMB2,619.1M.</li><li>Cash      flow by operating activities were RMB226.3M (+61.3% Y/Y); Cash &amp; equivalents      of RMB1,841.6M (+229.2% Q/Q) &amp; Short-term investments of RMB444M (+25.7%      Q/Q).</li><li>Capex      increased to RMB147.7M from RMB2.4M Y/Y, the increase was mainly due to      purchases of buildings &amp; leasehold improvements.</li><li><b>Q2 Outlook: </b>Net      revenues of RMB460-480M, which would represent an increase of 123.5%-133.2%      Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358117-sunlands-online-education-reports-q1-results\" target=\"_blank\">Sunlands Online Education reports Q1 results</a> (May 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358242\" data-linked=\"Sunlands Online Education down 4% despite strong Q1 result\" data-tweet=\"$STG - Sunlands Online Education down 4% despite strong Q1 result https://seekingalpha.com/news/3358242-sunlands-online-education-down-4-despite-strong-q1-result?source=tweet\" data-url=\"https://seekingalpha.com/news/3358242-sunlands-online-education-down-4-despite-strong-q1-result\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358238\" data-ts=\"1526910719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QURE\" target=\"_blank\">QURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358238-uniqures-amtminus-060-shows-treatment-benefit-in-hemophilia-b-patients-pre-existing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniQure&#39;s AMT-060 shows treatment benefit in hemophilia B patients with pre-existing neutralizing antibodies; shares up 3%</a></h4><ul><li>A <a href=\"https://seekingalpha.com/pr/17168807-uniqure-presents-new-data-demonstrating-clinical-benefit-hemophilia-b-patients-pre-existing\" target=\"_blank\">re-analysis</a> of pretreatment blood samples from a Phase 1/2 clinical trial assessing uniQure's (<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+2.7%</font>) AAV5 gene therapy AMT-060 in hemophilia B found that patients with pre-existing anti-AAV5 neutralizing antibodies still experienced a treatment benefit. The data were presented at ASGCT in Chicago.</li><li>CSO Sander van Deventer, M.D., Ph.D., says, &ldquo;These important data presented at ASGCT bolster our confidence that AAV5 gene therapies can provide successful liver transduction in all or nearly all patients. The study suggests that, in contrast to experience with other AAV vectors, detectable pre-existing neutralizing antibodies do not prevent successful gene transfer using AAV5 at clinical doses. In patients pre-exposed to AAV5 who tested positive for anti-AAV5 antibodies, therapeutic transgene expression was established with no cellular immune response observed after systemic administration of AAV5.&rdquo;</li><li>The appearance of neutralizing antibodies, the immune system's response to the presence of the viral capsid (shell of a virus) used to deliver a gene therapy, potentially interferes with its effectiveness.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358238\" data-linked=\"UniQure&#39;s AMT-060 shows treatment benefit in hemophilia B patients with pre-existing neutralizing antibodies; shares up 3%\" data-tweet=\"$QURE - UniQure&#39;s AMT-060 shows treatment benefit in hemophilia B patients with pre-existing neutralizing antibodies; shares up 3% https://seekingalpha.com/news/3358238-uniqures-amtminus-060-shows-treatment-benefit-in-hemophilia-b-patients-pre-existing?source=tweet\" data-url=\"https://seekingalpha.com/news/3358238-uniqures-amtminus-060-shows-treatment-benefit-in-hemophilia-b-patients-pre-existing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358229\" data-ts=\"1526909195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOXL\" target=\"_blank\">BOXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358229-premarket-gainers-of-9-05-05-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (05/21/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='green'>+23%</font>&nbsp;on&nbsp;exclusive <a href=\"https://seekingalpha.com/news/3358219-boxlight-announces-exclusive-partnership-multi-touch-interactives\" target=\"_blank\">partnership</a> with Multi Touch Interactives.</li>     <li><a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='green'>+16%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3358217-forward-industries-reports-q2-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MBFI' title='MB Financial Inc.'>MBFI</a> <font color='green'>+16%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3358137-fifth-third-buying-mb-financial-nearly-5b\" target=\"_blank\">acquired</a> by Fifth Third.</li>     <li><a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='green'>+16%</font>&nbsp;on extending Friday's <a href=\"https://seekingalpha.com/news/3358175-adomani-extends-fridays-pop\" target=\"_blank\">rally</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics'>NBRV</a> <font color='green'>+15%</font>&nbsp;as&nbsp;<a href=\"https://seekingalpha.com/news/3358162-nabrivas-lefamulin-par-moxifloxacin-late-stage-pneumonia-study\" target=\"_blank\">lefamulin</a> on par with moxifloxacin in late-stage pneumonia study.</li>     <li>SHLD <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358210-sears-bid-early-action\" target=\"_blank\">extending</a> a&nbsp;co-branded and private label credit card relationship with Citi.</li>     <li><a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='green'>+7%</font>&nbsp;on stage <a href=\"https://seekingalpha.com/news/3358152-avenue-therapeutics-32-percent-premarket-positive-late-stage-results-pain-med-iv-tramadol\" target=\"_blank\">results</a> for pain med IV tramadol.</li>     <li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358185-transenterix-5-percent-premarket-bullish-rbc-call\" target=\"_blank\">bullish</a> RBC call.</li>     <li><a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='green'>+6%</font>&nbsp;on V-Go distribution <a href=\"https://seekingalpha.com/news/3358188-valeritas-announces-v-go-distribution-agreement-austria-germany\" target=\"_blank\">agreement</a> in Austria and Germany.</li>     <li><a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-analyst-day-shares-plus-4_1-percent\" target=\"_blank\">raising</a> Q3 guidance.</li>     <li><a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='green'>+5%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-analyst-day-shares-plus-4_1-percent\" target=\"_blank\">acquired</a> by Blackstone.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358229\" data-linked=\"Premarket Gainers as of 9:05 am (05/21/2018)\" data-tweet=\"$BOXL $BOXL $FORD - Premarket Gainers as of 9:05 am (05/21/2018) https://seekingalpha.com/news/3358229-premarket-gainers-of-9-05-05-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358229-premarket-gainers-of-9-05-05-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358228\" data-ts=\"1526909176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358228-clean-energy-fuelsplus-8-premarket-looks-to-extend-five-session-win-streak\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy Fuels +8% premarket, looks to extend five-session win streak</a></h4><ul>     <li>Clean Energy Fuels (NASDAQ:<a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a>) shares could be ready to post their sixth straight gain, <font color='green'>+8.2%</font> premarket after rising during every trading session last week.</li>     <li>Insider buying has been strong, as CEO&nbsp;Andrew Littlefair <a href=\"https://www.sec.gov/Archives/edgar/data/1368265/000117911018007112/xslF345X03/edgar.xml\" target=\"_blank\">purchased</a> 22K shares and CFO Robert Vreeland <a href=\"https://www.sec.gov/Archives/edgar/data/1368265/000117911018007109/xslF345X03/edgar.xml\" target=\"_blank\">bought</a> 17.3K shares last Friday.</li>     <li>Shares have surged 27% since May 10, when CLNE reported Total had <a href=\"https://seekingalpha.com/news/3355193-total-buy-25-percent-stake-clean-energy-fuels-becoming-top-shareholder\" target=\"_blank\">acquired a 25% stake</a> in the company and agreed to provide as much as $100M in credit support alongside better than expected <a href=\"https://seekingalpha.com/news/3355441-clean-energy-fuels-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>     <li>CLNE says it is <a href=\"https://seekingalpha.com/filing/4032842\" target=\"_blank\">postponing</a> the date of its annual meeting to June 8 from May 30 to provide stockholders an opportunity to approve the \"pivotal and transformative\" deal with Total.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358228\" data-linked=\"Clean Energy Fuels +8% premarket, looks to extend five-session win streak\" data-tweet=\"$CLNE - Clean Energy Fuels +8% premarket, looks to extend five-session win streak https://seekingalpha.com/news/3358228-clean-energy-fuelsplus-8-premarket-looks-to-extend-five-session-win-streak?source=tweet\" data-url=\"https://seekingalpha.com/news/3358228-clean-energy-fuelsplus-8-premarket-looks-to-extend-five-session-win-streak\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358224\" data-ts=\"1526908720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358224-rokuplus-2_6-needham-says-bear-case-is-vanishing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +2.6% as Needham says bear case is vanishing</a></h4><ul>   <li>\"Flawless execution\" on tactics means the bear case on Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) is falling apart, Needham says in a bullish reiteration.</li>    <li>Shares are <font color='green'>up 2.6%</font> premarket, setting the stok up to build on a Friday where it <font color='green'>gained 3.3%</font>.</li>    <li>In particular, since the stock's debut the company has added the Roku Channel app, which Needham expects will appear on all of Roku's competitors' connected televisions, adding revenue optionality. User adds from Roku TVs are deepening the company's moat as well. (h/t Bloomberg)</li>    <li>Analyst Laura Martin reiterated her Buy rating and Street-high $50 price target, implying 41% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358224\" data-linked=\"Roku +2.6% as Needham says bear case is vanishing\" data-tweet=\"$ROKU - Roku +2.6% as Needham says bear case is vanishing https://seekingalpha.com/news/3358224-rokuplus-2_6-needham-says-bear-case-is-vanishing?source=tweet\" data-url=\"https://seekingalpha.com/news/3358224-rokuplus-2_6-needham-says-bear-case-is-vanishing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358223\" data-ts=\"1526908637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358223-galapagos-glpg1690-shows-positive-effect-in-mid-stage-ipf-study-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galapagos&#39; GLPG1690 shows positive effect in mid-stage IPF study; shares ahead 4% premarket</a></h4><ul><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;premarket, albeit on only 452 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17168659-glpg1690-results-ipf-published-lancet-respiratory-medicine-presented-ats\" target=\"_blank\">announcement </a>of results from a Phase 2a clinical trial assessing autotaxin inhibitor GLPG1690 in patients with ideopathic pulmonary fibrosis &#40;IPF&#41;. The data were presented at the American Thoracic Society Conference in San Diego.</li><li>Over a 12-week treatment period, patients patients receiving once-daily GLPG1690 experienced an increase of 8 mL from baseline in a measure of lung function called <a href=\"https://lunginstitute.com/blog/fev1-and-fvc/\" target=\"_blank\">forced vital capacity</a> &#40;FVC&#41; which is the amount of air a person can forcefully and quickly exhale after taking a deep breath. In patients treated with placebo, FVC dropped 87 mL from baseline. Declines in FVC characterize fibrotic lung diseases.</li><li>GLPG1690 is about to enter Phase 3 development for the indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358223\" data-linked=\"Galapagos&#39; GLPG1690 shows positive effect in mid-stage IPF study; shares ahead 4% premarket\" data-tweet=\"$GLPG - Galapagos&#39; GLPG1690 shows positive effect in mid-stage IPF study; shares ahead 4% premarket https://seekingalpha.com/news/3358223-galapagos-glpg1690-shows-positive-effect-in-mid-stage-ipf-study-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3358223-galapagos-glpg1690-shows-positive-effect-in-mid-stage-ipf-study-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358221\" data-ts=\"1526908369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358221-needham-lowers-applied-materials-target-to-37-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham lowers Applied Materials target to 37% upside</a></h4><ul><li>        Needham maintains a Strong Buy rating but lowers its Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) price target from $72 to $68, a 37% upside to Friday&rsquo;s close.</li><li>               Firm says AMAT reported a strong Q2 but mixed guidance on a near-term pullback on semiconductors. Management expects the business to recover by Q4 and sees a sustainable WFE in C19.&nbsp;</li><li>               Needham recommends that long-term investors use the near-term volatility as a buying opportunity.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Applied Materials shares are&nbsp;<font color='green'>up 2.3%</font>&nbsp;premarket to $50.63. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358221\" data-linked=\"Needham lowers Applied Materials target to 37% upside\" data-tweet=\"$AMAT - Needham lowers Applied Materials target to 37% upside https://seekingalpha.com/news/3358221-needham-lowers-applied-materials-target-to-37-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3358221-needham-lowers-applied-materials-target-to-37-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358220\" data-ts=\"1526908167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYHT\" target=\"_blank\">TYHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358220-premarket-losers-of-9-05-5-21-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (5/21/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358116-qudian-misses-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358137-fifth-third-buying-mb-financial-nearly-5b\" target=\"_blank\">buying</a> MB Financial for nearly $5B.</li><li><a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3358122-lexinfintech-misses-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3358220\" data-linked=\"Premarket Losers as of 9:05 am (5/21/2018)\" data-tweet=\"$TYHT $TYHT $QD - Premarket Losers as of 9:05 am (5/21/2018) https://seekingalpha.com/news/3358220-premarket-losers-of-9-05-5-21-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3358220-premarket-losers-of-9-05-5-21-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358212\" data-ts=\"1526907714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GHDX\" target=\"_blank\">GHDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358212-new-data-reinforce-positive-impact-of-oncotype-dx-gps-test-in-guiding-treatment-decisions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New data reinforce positive impact of the Oncotype DX GPS test in guiding treatment decisions</a></h4><ul><li>Genomic Health&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/GHDX' title='Genomic Health, Inc.'>GHDX</a>) <a href=\"https://seekingalpha.com/pr/17168934-new-data-reinforce-positive-impact-oncotype-dx-genomic-prostate-score-test-guiding-treatment\" target=\"_blank\">announces</a> results from two new studies demonstrating the positive impact of the Oncotype DX&nbsp;Genomic Prostate Score &#40;GPS&#41; test on risk assessment for better treatment decisions in low-risk prostate cancer patients.</li>   <li>An analysis performed on the first 29,000 Oncotype DX GPS tests showed that the test refined patient risk for approx. one in four men (26%). The largest shift in risk assessment in men (50%) was observed among NCCN low-risk patients. Of those who were reclassified, 35% had more favorable biology consistent with very-low risk, and 15% had less favorable with intermediate risk.</li>   <li>A prospective study of 1,200 men evaluated the impact of the GPS test on management decisions and persistence on active surveillance. One-year results demonstrated that use of the GPS test changed initial disease management for 25% of patients.</li><li>63% of the GPS-tested patient selected active surveillance compared to 40% of patients who did not receive the test. 89% of men who selected active surveillance, remained on it at one year.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3358212\" data-linked=\"New data reinforce positive impact of the Oncotype DX GPS test in guiding treatment decisions\" data-tweet=\"$GHDX - New data reinforce positive impact of the Oncotype DX GPS test in guiding treatment decisions https://seekingalpha.com/news/3358212-new-data-reinforce-positive-impact-of-oncotype-dx-gps-test-in-guiding-treatment-decisions?source=tweet\" data-url=\"https://seekingalpha.com/news/3358212-new-data-reinforce-positive-impact-of-oncotype-dx-gps-test-in-guiding-treatment-decisions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358209\" data-ts=\"1526907260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BX\" target=\"_blank\">BX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358209-hotel-reits-on-watch-following-4_8b-lasalle-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hotel REITs on watch following $4.8B LaSalle buyout</a></h4><ul><li>In the wake of Blackstone's (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a>) announced $4.8B deal to buy LaSalle Hotel Properties (NYSE:<a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a>), other hotel REIT shares could be poised to move.</li><li>Hospitality Properties Trust (NYSE:<a href='https://seekingalpha.com/symbol/HPT' title='Hospitality Properties Trust'>HPT</a>)&nbsp;<font color='green'>+1.0%</font>&nbsp;to $28.00 in premarket trading.</li><li>Here are some others to watch: Chatham Lodging Trust (NYSE:<a href='https://seekingalpha.com/symbol/CLDT' title='Chatham Lodging Trust'>CLDT</a>), Apple Hospitality REIT (NYSE:<a href='https://seekingalpha.com/symbol/APLE' title='Apple Hospitality REIT, Inc.'>APLE</a>), Ashford Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a>); Hersha Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/HT' title='Hersha Hospitality Trust'>HT</a>), Sunstone Hotel Investors (NYSE:<a href='https://seekingalpha.com/symbol/SHO' title='Sunstone Hotel Investors, Inc.'>SHO</a>), Park Hotels &amp; Resorts (NYSE:<a href='https://seekingalpha.com/symbol/PK' title='Park Hotels & Resorts Inc.'>PK</a>), and Host Hotels &amp; Resorts (NYSE:<a href='https://seekingalpha.com/symbol/HST' title='Host Hotels & Resorts, Inc.'>HST</a>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358177-blackstone-buy-lasalle-hotel-4_8b\" target=\"_blank\">Blackstone to buy LaSalle Hotel for $4.8B</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358209\" data-linked=\"Hotel REITs on watch following $4.8B LaSalle buyout\" data-tweet=\"$BX $BX $LHO - Hotel REITs on watch following $4.8B LaSalle buyout https://seekingalpha.com/news/3358209-hotel-reits-on-watch-following-4_8b-lasalle-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3358209-hotel-reits-on-watch-following-4_8b-lasalle-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358207\" data-ts=\"1526907003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358207-u-s-steel-ak-steel-tumble-on-trump-tariff-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel, AK Steel tumble on Trump tariff delay</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='red'>-1.4%</font> and AK&nbsp;Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>) <font color='red'>-1%</font> premarket, <a href=\"https://www.marketwatch.com/story/us-steel-ak-steel-shares-drop-after-china-trade-deal-2018-05-21\" target=\"_blank\">falling as much as 2.6%</a> at one point, following news that the Trump administration would <a href=\"https://seekingalpha.com/news/3358115-futures-soar-trade-war-on-hold\" target=\"_blank\">delay implementing tariffs</a> on Chinese imports into the U.S.</li>     <li>The delay comes three months after the administration recommended tariffs on steel and aluminum imports, which initially sent steel stocks surging but X shares have since sank 18.5% through Friday while AKS has tumbled 21%; Trump already delayed tariffs on the European Union, Mexico and Canada.</li><li>Other steel names on watch include <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358207\" data-linked=\"U.S. Steel, AK Steel tumble on Trump tariff delay\" data-tweet=\"$X $X $AKS - U.S. Steel, AK Steel tumble on Trump tariff delay https://seekingalpha.com/news/3358207-u-s-steel-ak-steel-tumble-on-trump-tariff-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3358207-u-s-steel-ak-steel-tumble-on-trump-tariff-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358206\" data-ts=\"1526906941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358206-campbell-soup-lower-after-baml-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Campbell Soup lower after BAML downgrade</a></h4><ul> <li>Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>) is <font color='red'>down 1.75%</font> in premarket action after Bank of America Merrill Lynch <a href=\"https://www.cnbc.com/2018/05/21/stocks-making-the-biggest-moves-premarket-googl-ge-mbfi-tsla-foxa-more.html\" target=\"_blank\">downgrades</a> the food stock with a new CEO due to take over. The analyst team also warns on rising costs and competition for Campbell Soup, as well as mounting debt.</li> <li>BAML moves to an Underperform rating after having Campbell Soup rated at Neutral.</li> <li>Separately, a banker <a href=\"https://nypost.com/2018/05/18/pinnacle-foods-under-pressure-from-activist-hires-investment-bank-to-mull-options/\" target=\"_blank\">tells</a> New York Post that Campbell's CEO announcement could indicate that the family trust is more open to a merger in the past. That development follows news that Pinnacle Foods has hired an investment banker for strategic advice.</li><li>Campbell Soup trades at a 52-week low.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3358206\" data-linked=\"Campbell Soup lower after BAML downgrade\" data-tweet=\"$CPB - Campbell Soup lower after BAML downgrade https://seekingalpha.com/news/3358206-campbell-soup-lower-after-baml-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3358206-campbell-soup-lower-after-baml-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358205\" data-ts=\"1526906894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358205-wedbush-raises-turtle-beach-target-to-25-upside-hearplus-4_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush raises Turtle Beach target to 25% upside; HEAR +4.8%</a></h4><ul><li>        Wedbush reiterates an Outperform rating on Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) and raises the price target from $12.50 to $20, a 25% upside to Friday&rsquo;s close.</li><li>               Analyst Alicia Reese: &ldquo;Fortnite exposes a large audience to multi-player games, which is greatly enhanced by communication and directional audio cues. This should benefit Turtle Beach for years to come.&rdquo;&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>                  Turtle Beach shares are&nbsp;<font color='green'>up 4.8%</font>&nbsp;premarket to $16.74.&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3358205\" data-linked=\"Wedbush raises Turtle Beach target to 25% upside; HEAR +4.8%\" data-tweet=\"$HEAR - Wedbush raises Turtle Beach target to 25% upside; HEAR +4.8% https://seekingalpha.com/news/3358205-wedbush-raises-turtle-beach-target-to-25-upside-hearplus-4_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3358205-wedbush-raises-turtle-beach-target-to-25-upside-hearplus-4_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358200\" data-ts=\"1526906494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358200-micron-raises-q3-guidance-ahead-of-analyst-day-sharesplus-4_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron raises Q3 guidance ahead of analyst day; shares +4.1%</a></h4><ul><li>        Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) <a href=\"https://seekingalpha.com/pr/17169015-micron-hosts-analyst-investor-event-updates-guidance-fiscal-third-quarter\" target=\"_blank\">increases</a> its Q3 guidance ahead of today&rsquo;s analyst day event.</li><li>               Q3 revenue is now expected from $7.7B to $7.8B (consensus: $7.47B; was: $7.2B to $7.6B) with EPS from $3.12 to $3.16 (consensus: $2.84; was: $2.76 to $2.90).&nbsp;</li><li>               Watch a live webcast of the 2018 Analyst and Investor Event <a href=\"http://investors.micron.com/\" target=\"_blank\">here</a> starting at 1:30 PM Eastern.&nbsp;</li><li>               Micron shares are&nbsp;<font color='green'>up 4.1%</font>&nbsp;premarket to $55.60.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358154-nxp-semiconductors-micron-among-movers-trade-war-hold\" target=\"_blank\">NXP Semiconductors, Micron among movers on trade war hold</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358200\" data-linked=\"Micron raises Q3 guidance ahead of analyst day; shares +4.1%\" data-tweet=\"$MU - Micron raises Q3 guidance ahead of analyst day; shares +4.1% https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-of-analyst-day-sharesplus-4_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3358200-micron-raises-q3-guidance-ahead-of-analyst-day-sharesplus-4_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>235&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358197\" data-ts=\"1526906290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358197-pinnacle-conagra-merger-speculation-picks-up-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle-ConAgra merger speculation picks up again</a></h4><ul>     <li>Investment bankers from Evercore Partners are <a href=\"https://nypost.com/2018/05/18/pinnacle-foods-under-pressure-from-activist-hires-investment-bank-to-mull-options/\" target=\"_blank\">digging</a> around at Pinnacle Foods (NYSE:<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a>), according to New York Post.</li>     <li>The development follows pressure from activist firm Jana Partners on Pinnacle management to pursue a merger with ConAgra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a>).</li>     <li>Jana has a 9.5% stake in Pinnacle.</li>     <li>Last month, Stephens said Pinnacle Foods could be worth as much as <a href=\"https://seekingalpha.com/news/3347193-conagra-seen-likeliest-buyer-pinnacle-foods\" target=\"_blank\">$85</a> in a takeover scenario.</li>     <li>Shares of Pinnacle are <font color='green'>up 2.72%</font> in premarket trading to $64.93.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358197\" data-linked=\"Pinnacle-ConAgra merger speculation picks up again\" data-tweet=\"$PF $PF $CAG - Pinnacle-ConAgra merger speculation picks up again https://seekingalpha.com/news/3358197-pinnacle-conagra-merger-speculation-picks-up-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3358197-pinnacle-conagra-merger-speculation-picks-up-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358194\" data-ts=\"1526906078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDP\" target=\"_blank\">HDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358194-analyst-upgrades-hortonworks-to-46-upside-sharesplus-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst upgrades Hortonworks to 46% upside; shares +2.7%</a></h4><ul><li>        Monness Crespi &amp; Hardt upgrades Hortonworks (NASDAQ:<a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a>) from Neutral to Buy with a $25 price target, a 46% upside to Friday&rsquo;s close.</li><li><b>                  </b>Firm says the price target is based on an EV/sales ratio of nearly 5.5x 2019E revenue.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Hortonworks shares are&nbsp;<font color='green'>up 2.7%</font>&nbsp;premarket to $17.53.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358194\" data-linked=\"Analyst upgrades Hortonworks to 46% upside; shares +2.7%\" data-tweet=\"$HDP - Analyst upgrades Hortonworks to 46% upside; shares +2.7% https://seekingalpha.com/news/3358194-analyst-upgrades-hortonworks-to-46-upside-sharesplus-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3358194-analyst-upgrades-hortonworks-to-46-upside-sharesplus-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358184\" data-ts=\"1526905788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDTX\" target=\"_blank\">CDTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358184-cidara-therapeutics-announces-offering-of-common-stock-and-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cidara Therapeutics announces offering of common stock and warrants</a></h4><ul> <li>Cidara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a>) has <a href=\"https://seekingalpha.com/pr/17168845-cidara-therapeutics-announces-offering-common-stock-warrants\" target=\"_blank\">entered</a> into a securities purchase agreement with certain investors, in a registered direct offering, of up to $120M of its common stock, in three closings.</li><li>Cidara will offer 10.6M shares of common stock in the first closing at a price of $4.70 per share, for the gross proceeds of ~$50M. The first closing date is May 23.</li>   <li>In the second closing, Cidara may sell up to an additional $50M of shares of common stock to investors who purchased at least $1M of shares in the first closing&nbsp;(the &ldquo;Major Purchasers&rdquo;) at a price per share equal to 75% of the volume of the common stock for the five trading days following Cidara&rsquo;s public release of STRIVE trial&nbsp;.</li>  <li>In an optional third closing, to be held five trading days following the second closing, purchasers who participate in the second closing may, purchase up to an additional $20M of common stock at a price per share equal to the purchase price of the shares at the second closing.</li><li>In a private placement concurrent with the first and third closing, Cidara is also selling warrants, at a price of $0.125 per share, to purchase 12.5M and 2.5M shares of common stock, respectively.</li><li>The warrants will be exercisable at a price of $6.81 per share, and will expire five years from the date of the respective closing.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358148-cidara-therapeutics-files-form-sminus-3-additional-shares-common-preferred-stock\" target=\"_blank\">Cidara Therapeutics files Form S-3 for additional shares of common and preferred stock</a> (May 21)</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3358184\" data-linked=\"Cidara Therapeutics announces offering of common stock and warrants\" data-tweet=\"$CDTX - Cidara Therapeutics announces offering of common stock and warrants https://seekingalpha.com/news/3358184-cidara-therapeutics-announces-offering-of-common-stock-and-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/3358184-cidara-therapeutics-announces-offering-of-common-stock-and-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358186\" data-ts=\"1526905565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KELYA\" target=\"_blank\">KELYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358186-kelly-services-higher-after-northcoast-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kelly Services higher after Northcoast confidence</a></h4><ul> <li>Shares of Kelly Services (NASDAQ:<a href='https://seekingalpha.com/symbol/KELYA' title='Kelly Services, Inc.'>KELYA</a>) are active in the premarket session after Northcoast Research upgrades the staffing services stock to Buy from Neutral.</li> <li>The Northcoast analyst team sets a price target of $31 to rep 37% upside poential.</li> <li>Kelly Services fell earlier in the month when the company's full-year revenue <a href=\"https://seekingalpha.com/news/3355284-kelly-services-sharply-guidance-update\" target=\"_blank\">guidance</a> fell just short of the consensus estimate.</li> <li>KELYA&nbsp;<font color='green'>+3.01%</font>&nbsp;premarket to $23.24.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3358186\" data-linked=\"Kelly Services higher after Northcoast confidence\" data-tweet=\"$KELYA - Kelly Services higher after Northcoast confidence https://seekingalpha.com/news/3358186-kelly-services-higher-after-northcoast-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3358186-kelly-services-higher-after-northcoast-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358185\" data-ts=\"1526905551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358185-transenterix-up-5-premarket-on-bullish-rbc-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransEnterix up 5% premarket on bullish RBC call</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on modest volume on the heels of an RBC note citing bullish prospects for its Senhance system.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330972-transenterix-files-u-s-marketing-application-expanded-use-senhance-shares-8-percent-premarket\" target=\"_blank\">TransEnterix files U.S. marketing application for expanded use for Senhance; shares up 8% premarket</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358185\" data-linked=\"TransEnterix up 5% premarket on bullish RBC call\" data-tweet=\"$TRXC - TransEnterix up 5% premarket on bullish RBC call https://seekingalpha.com/news/3358185-transenterix-up-5-premarket-on-bullish-rbc-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3358185-transenterix-up-5-premarket-on-bullish-rbc-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358183\" data-ts=\"1526905224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358183-cheetah-mobileminus-3-on-q1-report-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile -3% on Q1 report with downside guidance</a></h4><ul><li>        Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>)&nbsp;<font color='red'>drops 3%</font>&nbsp;premarket on Q1 results that missed EPS and revenue estimates. Downside Q2 guidance has revenue from RMB1.02B to RMB1.08B (consensus: RMB1.14B).</li><li>               <a href=\"https://seekingalpha.com/pr/17168773-cheetah-mobile-announces-first-quarter-2018-unaudited-consolidated-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358135-cheetah-mobile-beats-rmb0_03-beats-revenue\" target=\"_blank\">Cheetah Mobile beats by RMB0.03, beats on revenue</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3358183\" data-linked=\"Cheetah Mobile -3% on Q1 report with downside guidance\" data-tweet=\"$CMCM - Cheetah Mobile -3% on Q1 report with downside guidance https://seekingalpha.com/news/3358183-cheetah-mobileminus-3-on-q1-report-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3358183-cheetah-mobileminus-3-on-q1-report-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358182\" data-ts=\"1526905160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358182-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>AMAG Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a>) initiated with Market Perform rating and $26 (5% upside) price target at Leerink.</li><li>Achillion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a>) upgraded to Equal Weight with a $5 (35% upside) price target at Barclays. Shares up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li><li>Sabra Healthcare REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a>) upgraded to Outperform with a $22 (15% upside) price target at Raymond James.</li><li>Healthcare Trust of America (NYSE:<a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a>) downgraded to Market Perform with a $29 (19% upside) price target at Raymond James.</li><li>Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) downgraded to Equal Weight with a $79 (2% upside) price target at Morgan Stanley.</li><li>Prothena (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTA' title='Prothena Corp plc'>PRTA</a>) downgraded to Underweight with a $12 (21% downside risk) price target at Barclays following the company's termination of NEOD001 development. Shares down&nbsp;<font color='red'>4%</font>&nbsp;premarket.</li><li>Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) downgraded to Neutral with a $57 (8% upside) at UBS citing a less bullish outlook for top-seller Opdivo after after it released results from a late-stage lung cancer study in April.</li></ul><div class=\"tiny-share-widget\" data-id=\"3358182\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$AMAG $AMAG $ACHN - Premarket analyst action - healthcare https://seekingalpha.com/news/3358182-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3358182-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358178\" data-ts=\"1526904812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPF\" target=\"_blank\">APPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358178-appfoliominus-2_6-on-morgan-stanley-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AppFolio -2.6% on Morgan Stanley downgrade</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+AppFolio+%28APPF%29+to+Underweight/14216511.html\" target=\"_blank\">downgrades</a> AppFolio (NASDAQ:<a href='https://seekingalpha.com/symbol/APPF' title='AppFolio'>APPF</a>) from Equal Weight to Underweight.</li><li>               AppFolio shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;premarket to $56.30. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358178\" data-linked=\"AppFolio -2.6% on Morgan Stanley downgrade\" data-tweet=\"$APPF - AppFolio -2.6% on Morgan Stanley downgrade https://seekingalpha.com/news/3358178-appfoliominus-2_6-on-morgan-stanley-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3358178-appfoliominus-2_6-on-morgan-stanley-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358175\" data-ts=\"1526904447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADOM\" target=\"_blank\">ADOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358175-adomani-extends-on-fridays-pop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADOMANI extends on Friday&#39;s pop</a></h4><ul> <li>ADOMANI (NASDAQ:<a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a>) <font color='green'>jumps 25%</font> in premarket trading on share volume of over 270K. The upward spike follows a 78% pop on Friday.</li> <li>Last week, the company <a href=\"https://www.nasdaq.com/press-release/adomanir-backlog-increases-41-to-65m-with-recent-purchase-order-for-electric-school-bus-drivetrain-20180517-01197\" target=\"_blank\">announced</a> its backlog of orders increased 41% after it took down a $6.5M order from Blue Bird for electric drivetrain systems.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3358175\" data-linked=\"ADOMANI extends on Friday&#39;s pop\" data-tweet=\"$ADOM - ADOMANI extends on Friday&#39;s pop https://seekingalpha.com/news/3358175-adomani-extends-on-fridays-pop?source=tweet\" data-url=\"https://seekingalpha.com/news/3358175-adomani-extends-on-fridays-pop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3358168\" data-ts=\"1526903855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDSO\" target=\"_blank\">MDSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3358168-medidata-solutionsminus-1_3-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medidata Solutions -1.3% on analyst downgrade</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Medidata+Solutions+%28MDSO%29+to+Equalweight/14216512.html\" target=\"_blank\">downgrades</a> Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) from Overweight to Equal Weight.</li><li>               Price target: $79, a 2% upside to Friday&rsquo;s close.&nbsp;</li><li>               Medidata shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;premarket to $76.50&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3358168\" data-linked=\"Medidata Solutions -1.3% on analyst downgrade\" data-tweet=\"$MDSO - Medidata Solutions -1.3% on analyst downgrade https://seekingalpha.com/news/3358168-medidata-solutionsminus-1_3-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3358168-medidata-solutionsminus-1_3-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}